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Resumo  
Esta dissertação tem como objectivo principal implementar um processo formal de 
monitorização dos principais concorrentes da unidade de negócios "healthcare IT" da empresa 
Siemens healthcare. Para tal, foi criada uma ferramenta em excel que suporta as actividades 
relacionadas com monitorização e análise dos concorrentes: angariação, segmentação e 
armazenamento de informação e apresentação resumida da informação armazenada. 
Para a realização deste trabalho foi necessária a revisão de literatura sobre o tema 
"competitive intelligence", na qual foi abordada a teoria desenvolvida em torno deste tema, as 
melhores práticas utilizadas pelos profissionais de "competitive intelligence" e a forma como 
as empresas em vários países estão a conduzir as actividades relacionadas com monitorização 
da concorrência. 
A plataforma, constituída pelas ferramentas e documentos de apoio a todo processo de 
monitorização da concorrência, foi implementada no departamento onde projecto decorreu. 
No entanto, também teve como objectivo servir de projecto piloto para uma futura instalação 
em toda a unidade de negócio de "healthcare IT" de uma plataforma com características 
semelhantes. Portanto, para além do desenvolvimento da plataforma para o departamento de 
"business development", também foi conceptualizado o desenvolvimento e a implementação 
de uma plataforma com maior abrangência para toda a unidade de negócio "healthcare IT". 
Esta dissertação é também composta por um segundo projecto, de menor dimensão, que 
consiste na avaliação de um negócio. Devido a factores relacionados com a confidencialidade, 
este projecto foi abordado de uma forma mais teórica não revelando muitos aspectos da parte 
prática do projecto. Para a realização desta parte da dissertação, foi conduzida uma revisão 
bibliográfica aos métodos de avaliação mais comuns, assim como um análise aos métodos de 
avaliação utilizados na indústria de "healthcare IT".   
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Abstract 
This work has the purpose to develop to Business Develop (BD) department of Siemens 
Healthcare IT, a framework to support a formal process of monitoring the competitors. An 
extensive literature review about competitive intelligence was conducted in order to 
understand what are the best practices are as well as understand how companies are currently 
conducting CI activities. 
The framework was specially developed for the BD department, but it has also served as a 
mock-up project to the development of a competitive intelligence platform for the entire 
healthcare IT business unit. So besides the platform for the BD department, a suggestion of 
implementation and adaptation of such a tool for the entire healthcare IT business unit was 
also developed in this project. 
The second and smaller project consists in the valuation of a business. As this topic was 
considered critical for Siemens AG the developments core must be confidential and cannot be 
disclosed any details from this project. A literature review with focus on valuation methods 
was also conducted as well as a review on the way business are being valued in the IT market. 
Although it isn´t possible to describe the project in detail, the methods and different practices 
adopted were described whenever possible, discussing the differences exist between the 
theory and the practices followed by the company. 
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1. Introduction 
This thesis describes the work developed in a business environment for the Dissertation 
course of the Master in Industrial Engineering and Management from Faculdade de 
Engenharia da Universidade do Porto. The project took place at the Healthcare sector from 
Siemens AG in the international Business Development department. This chapter starts by 
describing the context in which the dissertation was developed and then presents the objective 
of the work developed for the project. 
1.1. Siemens Healthcare IT Business unit 
Siemens A.G. is a global company with a diversified product portfolio. Its business spans 
between 4 four distinct sectors: Energy, Healthcare, Industry and Infrastructure & Cities 
(Siemens, 2014). Along with its three core divisions of the Healthcare sector - Imaging and 
Therapy Systems, Clinical Products, Diagnostics - Siemens Healthcare AG has a division 
devoted to the Healthcare IT: the Health Services (HS) Business Unit (BU). The HS BU, with 
focus on hospital information systems (HIS), offers a broad range of clinical and financial IT 
applications, as well as outsourcing and professional services to support health providers 
across the continuum of care. The health services product portfolio consists of Hospital 
Information systems, Health information exchange systems (HIE systems) Archiving and 
documentation solutions, Business Intelligence solutions and Managed services. 
1.2. Introduction to Healthcare Information Technology  
Decisions of healthcare professionals are based on a great amount of information. Physicians 
and nurses need different types of information about the patient during the whole care process 
such as patient history, lab results or radiology exams. Healthcare professionals in hospital 
administration and management, as well as other non care-providers entities such as insurance 
companies must also be provided with a vast amount of information (Winter et al., 2011).  
Thus, information processing is an important quality factor in health care, particularly in 
hospitals.  
HIT is the application of information processing, involving both hardware and software that 
deals with the storage, retrieval, sharing and use of health care information data, creating 
knowledge for communication and decision making (Goldschmidt, 2005). In other words 
HIT, which comprises the use of the hardware and software in an effort to manage and 
manipulate information, consists of the application of information technology (IT) to 
healthcare. Since it encompasses a lot of different technologies, several potential levels of 
applications and stakeholders (e.g. vendors, governments, payers, patients, pharmacies, 
hospitals, hospitals, among others), HIT spans a wide range of dimensions and type of 
systems (Ciampa & Revels, 2012).  
IT has been embraced later and adopted with a slower pace in healthcare than in other 
industries - such as banking - due to several reasons. First, there is a high fragmentation 
among doctors groups, which typically use different kinds of systems, what makes automation 
and information connection difficult. Second there is a shortage of trained healthcare 
technology professionals, who must be specifically trained for this industry and be aware of 
all the Governments regulations that play a great role in the HIT systems deployment (Ciampa 
& Revels, 2012). There was a first wave of IT in healthcare in 1950s, when organizations 
began to use IT to process vast amounts of data and to automate and standardize repetitive 
tasks. A second wave of adoption came 20 years later and it was characterized by the effort of 
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promoting the use of HIT by several entities and also by the stakeholders’ focus on the 
integration of the information available. Now, many institutions are already entering in the 
third wave of IT adoption, which consists in the digitalization of their entire enterprise – 
digital products, channels and processes - and starting to use advanced analytics to make 
better decisions. Additionally to this focus towards a fully integrated digital healthcare 
system, players in healthcare industry are moving from an IT adoption focused on processes 
to a more patient focused approach, which comes along with privacy and regulatory concerns 
(Biesdorf & Niedermann, 2014). 
1.2.1. Healthcare IT market 
The market size of the global HIT was estimated to be approximately $170 billion in 2012 
and expected to grow 4% annually through 2016 (Calton, 2013). Because of the complexity of 
the US healthcare system, its government stimulus and earlier investments in IT, the US IT 
market represents the largest HIT global market share with approximately 60%, followed by 
Japan with just 7% (Calton, 2013).  
In Europe the market is difficult to define and to enter, because each country has its own 
healthcare climate due to differing approaches to healthcare administration. This gets even 
more complicated when the healthcare governance system of the country, such as the one of 
Italy creates different regional markets where each administrative zones has authority to set 
unique rules and guidelines (Lynn, 2011). Nevertheless, Europe is frequently the choice for 
market expansion for the vendors of HIT systems. 
Thanks to the "National Program for IT", United Kingdom (U.K.) is the country in Europe 
which spends more on HIT (4% of the global market) followed by Germany and France, each 
of them representing approximately 2% of the global market (R. Anderson, 2005; Calton, 
2013). Emerging markets such as China and India are in an early stage of implementing IT in 
the healthcare, but are the countries experiencing the highest growth rate of the HIT market 
(Calton, 2013).  
It is difficult to make comparisons among countries, because healthcare infrastructure varies 
widely in developed countries, as does the organization and funding of health services and the 
patients' behavior. Moreover, there are countries such as Sweden and U.S that have been 
spending heavily for a while on IT, whereas others are just starting to spend seriously in IT 
related to Healthcare. This leads to different needs of Healthcare IT among the countries and 
consequently different industry´s characteristic (Marketsandmarkets, 2013). For instance, in 
US a great proportion of the IT market is dedicated to the complex billing systems, made 
necessary by the way health system is organized and how providers and payers interact 
between them.  
Another example of the differences between countries is the fact that U.K. is a strong adopter 
of the electronic booking, while in countries like France and Germany, this type of systems 
don´t have any adoption, since patients go directly to specialists, rather than through GP 
referrals (as it happens in U.K). Countries also have different priorities: cost control and 
efficiency drive IT strategies in Sweden and U.S.A, while Germany has a major focus on 
solving the problem of fragmented information that exists between different providers (R. 
Anderson, 2005). 
So, although the HIT will be addressed as a global market, it is important to retain that the 
HIT market has different characteristics and it is in different stages of adoption among the 
different countries in the world, which produces varying HIT requirements.  
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1.2.2. How IT is influencing Healthcare 
Currently there are some trends emerging that are crucial to the vitality of the Healthcare IT 
market. One of them is E-health, defined by (Eysenbach, 2001) as:  
“an emerging field in the intersection of medical informatics, public health and business, 
referring to health services and information delivered or enhanced through the internet and 
related technologies, that characterizes not only a technical development but also a state-of-
mind, a way of thinking, an attitude and a commitment for networked, global thinking to 
improve healthcare locally, regionally and worldwide by using information and 
communication technology.”  
E-health is bringing some benefits to healthcare, such as an increased access to information, 
better match of users’ needs and better education of individuals with poor health education. 
Furthermore, it also gives the patients the chance to reach out in search of effective strategies 
for managing their own health (Oenema, Brug, & Lechner, 2001). The e-health paradigm gets 
even more powerful with its recent upgrade m-health, which encompasses mobile 
communications and network technologies for healthcare systems and represents the 
evolution of the traditional e-health systems from desktops platforms and wired connections 
to the use of more compact devices and wireless connections in e-health systems (Beaver, 
1998; Istepanian, Laxminarayan, & Pattichis, 2007). 
There are several factors that are driving the growth of IT adoption in the healthcare industry. 
The most consensual and important reason is the cost pressure that healthcare providers are 
experiencing. Healthcare costs are rising in most countries – for example the U.S shows five 
years of consecutive annual double-digit increases (Beaver, 1998). At the same time, because 
of the aging population, there is an increase in the demand for healthcare and patients are 
becoming more challenging by requiring higher quality. This need to cut healthcare costs, 
along with the requirement of an improvement in quality and efficiency, has lead providers to 
use HIT investment as a strategy to reduce operating costs and improve efficiency of 
healthcare delivery. If the data and knowledge is accessed and interpreted in the right way, 
HIT enables not only to enhance administrative and clinical workflows and optimize the 
health information management, but also to enhance decision-making in the clinical scope. 
Examples of these enhancements are reduction of costs by eliminating double treatments and 
exams, process optimization by reducing the need to physically retrieve patient´s charts and 
files and minimizing human error. Moreover, an efficient HIT framework provides the 
practitioners the time and freedom to focus on their core competencies and therefore increase 
the outcomes of the healthcare system (Beaver, 1998).  
In a study presented by Gartner1, where the potential benefits of an increased usage of e-
health in 5 EU member states (Czech Republic, France, the Netherlands, Sweden, Spain and 
U.K.) were analyzed, was concluded that five million yearly outpatient prescription errors 
could be avoided, 100 000 yearly inpatient adverse drug events could be avoided through 
Computerized Physician order entry (CPOE) and clinical decision support. This would make 
7000 beds free yearly. Furthermore, the increased usage of the e-health would also avoid 49 
000 cases of inpatient Hospital Acquired Infections every year through the use of business 
intelligence and data mining for real time detection, as well as 11,000 deaths caused by 
complications could be reduced through EMR with chronic disease management capabilities. 
                                                
1 http://www.sweden.gov.se/content/1/c6/12/98/15/5b63bacb.pdf 
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At last, telemedicine and home health monitoring would avoid 5.6 million admissions to 
hospitals for chronically ill patients (Winter et al., 2011).  
Also in order to cut costs and to have more flexibility, by purchasing what they need when 
they need and to obtain a tailored solution, hospitals are beginning to reduce their IT 
departments and starting to use software as a service (SaaS) (Bowman, 2014). In SaaS 
models, organizations secure applications from other companies, what allows them to bypass 
the risk associated with maintaining and upgrading networks, computers and software 
applications. Consequently, organizations don´t need to spend time with activities that support 
the IT platform and don´t have to invest in an infrastructure to support this platform 
comprised of computers, servers to store the data and the maintenance that is required. These 
cloud-based services also provide the chance to the end-user to work in a pay-per-use capacity 
according to the business needs and give the chance to the user to update fast to modern 
systems (Bowman, 2014).   
Encouragements and initiatives from the governments play a crucial role on the development 
and growth of the HIT market. In some cases, such as in the U.S, the government implements 
programs – Health Information Technology for Economic and Clinical Health (HITECH) Act 
– under which the providers are obliged to adopt IT best practices and infrastructures. Along 
with the governments´ encouragements, which have the intention of moving the healthcare 
systems towards a more integrated one, is coming another shift: the evolution from clinic 
centric model to a patient centric model. Following this shift, providers are moving from 
Electronic medical records (EMRs), which are a digital record of patient´s information found 
in clinicians’ office, to electronic health records (EHRs), which have the goal of covering the 
total health of the patient in order to provide the users of EHRs a comprehensive and holistic 
perspective of the patient´s health (Winter et al., 2011). This way of storing information about 
the patient is crucial to the new patient centric model and contributes to the achievement of its 
ultimate goal of letting all the healthcare providers – such as physicians, specialists, nursing 
facilities and hospitals - act as a team (known as care coordination team) by sharing their 
perspectives on the patients’ health (Beaver, 1998; Rodrigues, 2009).   
1.2.3. Integrating healthcare information and systems 
In order to move towards care coordination goals and also due to the ever more highly 
specialized and distributed patient care, it is crucial to have integration between all the 
entities. Therefore, a recent concept is gaining importance and adherence in the HIT industry: 
Unified information management (UIM). UIM is a concept that encompasses the connection 
and exchanging of data between two or more entities and is supported by Health Information 
exchange (HIE) systems – archiving and networking solutions that enable the share of health-
related information among organizations. The components of Unified Information 
Management that are used depend on specific customer requirements. A UIM project can 
range from a small project to a system responsible to connect and store the data of a whole 
country in a central unity (Health Information Exchange Steering Comitee, 2009; Siemens 
Healthcare, 2014). This ability to exchange information electronically through the HIEs 
systems is a basic and critical capability to improve healthcare, since it enhances the 
communication with patients, between practitioners and among the community stakeholders, 
leading to better health management of the patients and decision making by the health 
practitioners (Winter et al., 2011). Moreover, it provides the means to reduce duplication of 
services with a resultant reduction of healthcare costs and provides a connecting point for an 
organized, standardized process for data exchange across local, regional and country wide 
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HIT initiatives. HIEs will ultimately provide a single health record view for each patient that 
is one of the healthcare organizations goals today (Health Information Exchange Steering 
Comitee, 2009). An example of an UIM project is the NHS National Programme for IT 
(NPfIT)2 in the U.K, whose goal is to move the National Health Service towards a single, 
centrally-mandated electronic care record for patients and to connect 30 000 practitioners to 
300 hospitals.  
1.2.4. Big data in Healthcare IT 
More and more data becomes available free of charge and some specialists argue that the 
future of Healthcare will be in the ability to analyze these data with intelligent algorithms, 
which may enhance decisions, identify opportunities, make better diagnosis and preventions. 
It is believe that it will also contribute to a better management of the health of populations. 
Governments and other stakeholders are beginning to move towards transparency in the 
healthcare by making healthcare related data usable and searchable3 (Population Health 
Management Solutions and Strategies, 2014).  Consequently, healthcare is experiencing an 
increase in the healthcare data liquidity, diversity and complexity (Groves & Knott, 2013). At 
the same time, technology advances in the industry are gaining the ability of taking advantage 
of analytics applications from HIS applied to Big Data, which is expected to transform the 
healthcare industry in many ways. An example of that are the decision support systems, which 
comprise clinical analytics solutions and business intelligence solutions. These systems 
extract multiple types of data – clinical, financial, operating, supply-chain, human resources, 
among others – that are used to support and enhance decision-making from different 
functions.  
On the clinical dimension of healthcare, this type of technology associated with big data is 
already playing a significant role. Clinical decisions support systems that compare patient 
information against research literature and medical guidelines are already available, alerting 
to potential errors or dangers such as adverse drug reactions. Furthermore, it is expected that 
they will be essential to the clinical process by enhancing the evidence-base care and 
efficiently prevent complications, new disease developments of patients and helping 
physicians make the final decisions about diagnosis and treatments. They will be important to  
enhance the drug prescriptions or even the track the high-cost patients, who are responsible 
for about half of all health care spending in US. On a more operational dimension, there is the 
example of decisions support systems supporting research organizations in optimizing 
operations and strategic planning as well as helping Pharmaceutical companies to predict 
disease trends (Health Information Management Systems Society, 2014).  
Now that a great part of healthcare organizations has a robust and integrated IT structure 
installed, relevant data is easily accessible. HIT is entering in a new phase, where integration 
of information is a requirement and where taking advantage of these big data by enhancing 
the decisions and getting insights from them will be essential to achieve success (Piai & 
Claps, 2013).  
                                                
2 www.connectingforhealth.nhs.uk 
3 www.healthdata.gov is an US government website dedicated to make health data accessible 
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1.2.5. HIT systems  
Healthcare information systems (HIS) provide the informatics platform that enables all the 
benefits and efficiencies stated before. HIS collects data that can be used across a number of 
systems of many different purposes (Winter et al., 2011). One major category of the HISs are 
the hospital information systems. 
A hospital information system has many different aspects incorporated within itself and 
therefore different types of systems. The type of systems that are comprised by a hospital 
information’s systems can be defined as Clinical information systems (CIS) and non-clinical 
information system (NCIS) (Calton, 2013).  
NCISs include applications that address the financial and operational aspects of a healthcare 
organization, such as cost accounting, staffing levels, budgeting and facility management. CIS 
includes applications that address aspects of the health practice such as care delivery, drug 
efficacy and population health management (Beaver, 1998; Rodrigues, 2009).  
HISs are generally composed by a great number of different applications that support the 
needs of many type of organizations interacting with each other in the healthcare industry 
(EMRconsultant 2014).  
HIS´s applications typically used in a CIS are the Electronic Health Record (EHR) system, 
order entry system also known as Clinical Physician Order Entry (CPOE), Laboratory 
information system (LIS), decision support systems, pharmacy information system and 
nursing system (www.emrconsultant.com, 2013). While on the non-clinical dimension of the 
HIS, the most used application are patients administration systems, financial information 
systems and HR-related systems.  
As mentioned before, the HIT market varies widely from country to country and applications 
that are usually used in one country can have no adoption in others. Since they constitute a 
great part of the revenue for the HIT vendors, the services related to the HISs, provided by 
these vendors are usually considered as part of the HIT business. The services related to 
Healthcare IT are usually IT consulting, development integration and maintenance of the 
system acquired, Business Process optimization (BPO) and as hosting and IT outsourcing.  
1.3. Objective of the work described in this thesis 
The work described in this thesis is related to two projects developed in the field of 
competitive intelligence (CI) and business valuation in the Healthcare Information 
Technologies (HIT) business unit of Siemens AG. Both projects were supported by an 
extensive literature review that is presented in the thesis. The CI project consists in the 
development of a framework to support the process of gathering, storing and disseminating 
information about the competitors. The part devoted to the business valuation project is 
approached with focus on the theory, since the project details are confidential and can´t 
therefore be disclosed. 
The first and main project consists in the development of a competitive intelligence 
framework (CIF) to the business development (BD) department, as well as a proposal for its 
adaptation to the whole HIT Business Unit of the company. Before developing the 
framework, a review of competitive intelligence literature was executed, where it was 
reviewed what the authors understand by the term CI, as well as the importance of the CI 
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activities and how they should be performed. During the literature review was also addressed 
the way companies are performing CI related activities. 
The goal of the framework to be developed in this project is to create a platform that enables 
the BD department to store information about the competitors in a way that it is easier to 
access and enables the user to obtain a completed and updated “big picture” of the main 
competitors. In order to achieve these goals, to automate some of the CI analyst activities and 
according to the specifications required by Siemens BD HIT managers, the framework is 
composed by the following components: 
• An excel file with 3 databases containing information about competitors and a 
dashboard that presents the information contained in the databases in a comprehensive 
and aggregated way, i.e. through charts and tables. 
• A design of tasks to regular be undertaken by the CI analyst, who is responsible for 
administrating the database by updating its records and redesigning the framework as 
required. 
• A set of support documents, which are intended to support the activities related with 
the CI framework - such as data gathering - as well as to contribute to a continuous 
improvement of the whole process related to the CIF. 
Since such a tool would be more powerful and useful if used by all employees, a roadmap has 
been suggested for adopting the CIF in the whole Healthcare IT division. This was presented 
to the team responsible for the competitive intelligence of the Business Unit and is described 
in detail in the chapter dedicated to the Project of Competitive Intelligence Framework. 
The second and smaller project also described in this dissertation consists in the valuation of a 
business. As this topic was considered critical for Siemens AG the developments core must be 
confidential and cannot be disclosed any details from this project. However, since it was a 
project to which a lot of time was devoted, it was decided to include it in the master thesis. A 
literature review with focus on valuation methods was also conducted as well as a review on 
the way business are being valued in the IT market. Although it isn´t possible to describe the 
project in detail, the methods and different practices adopted were described whenever 
possible, discussing the differences exist between the theory and the practices followed by the 
company. 
Besides the development of the previous described projects, a lot of time was devoted to tasks 
that won´t be mentioned in this dissertation. These task include the management of the whole 
recruitment process of the next intern, development and enhancement of presentations, 
researches documents about specific topics to support managers in meetings, analysis and 
translation of contracts, among others administrative tasks. 
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2. Literature Review – Competitive Intelligence 
2.1. Introduction 
On the present era the amount of information created in the entire world is doubling every 40 
months and the world is getting highly connected. Due to this, there is a rapidly changing of 
business environments. Therefore, mastering the process of information creation and 
transforming it into intelligence - what supports a wide range of decisions-types - is getting 
crucial for every company (B. Anderson, 2014; McAfee & Brynjolfsson, 2012).  
Although competitive intelligence (CI) activities can be useful for different functions of a 
company, in this master thesis the focus will be on the importance of CI at a strategy level 
since the majority of tasks done during the internship were related the strategy of the 
company.  
In studies conducted about companies from different industries was found that for most of 
them the goal of the CI activities was to support strategy decisions (Muller, 2007). This 
happens because CI is produced essential to understand better an industry as well as the 
company itself and the competitors. Therefore it is crucial to the formulation of the strategy 
(Bose, 2008).  
Wright (2010) states that typical provisions and advantages of CI activities to the strategic 
decision making process are: an objective view of the market place; a reduction in decision 
making time; minimizing risk and avoiding surprises; identification of opportunities before 
the competition does; identification of early warning signals of competitor moves; verification 
of assumptions; support for prioritization of decisions as well as   reduction in uncertainty. 
The literature review of CI reported in the remainder of this chapter is composed by a first 
part where several definitions attributed to CI are discussed. The second part is devoted to the 
state-of-art of the CI, describing the way companies are executing CI activities and what their 
goals are. The results from studies that compared CI activities among different countries are 
also presented.  
The third part is devoted to a review of the literature from different CI processes 
conceptualized by different authors, with focus on a recent study that created an universal CI 
process model by analyzing several different models from the literature. It is important to 
mention that this particular section will serve as the theoretical guideline to the development 
of the CI project presented in this thesis.  
The last part describes typical CI activities and their relevance to strategy formulation. This 
chapter also addresses the important role that the CI analyst represents in the intelligence 
producing process.  
2.2. Defining Competitive intelligence 
Among researchers and practitioners, there is no consensus over the definition of Competitive 
intelligence (CI) since the concept is extremely broad and sometimes it refers to different 
subjects. In the literature, several definitions of CI covering different scopes and functions 
might be found.  
Murphy (2005) explains that "CI is now so catholic in its range of concerns it becomes 
difficult to know where to fix its boundaries, since it is intertwined with functions such as 
market research, business information and knowledge management." Attaining an accurate 
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and consensual definition becomes even harder when intelligence practitioners use different 
terms. For example, terms like competitive intelligence, business intelligence, market 
Intelligence and corporate Intelligence are often used interchangeably or as synonyms 
(Ettorre, 1995).   
Murphy (2005) defines CI as being the "transmutation of intelligence into shared learning 
within an organization that provides an informed basis for its corporate actions". Anica-Popa 
and Cucui (2009) state that CI is the acquisition and use of information about new and 
existing competitors, customers, suppliers and competing industries, in order to support 
decision making process for enhancing competitiveness of organization.  In a more general 
and broad approach, Global Intelligence Alliance (2004) defines CI as knowledge and 
foreknowledge about the external operating environment, whose key goal should be 
facilitating a more effective strategic planning, providing decision-maker with early warnings 
of future events, which may have an impact on company´s performance and produce insights 
about the competitors` capabilities and intentions. Also Bergeron and Hiller (2002) have a 
broad definition for CI. They claim that CI covers various areas of intelligence including 
competitors, technology, product/service, environment (ecology), economy, legislation, 
regulation, mergers and acquisitions, customers, suppliers, market, partners, social 
environment, and the internal environment of the organization, with the objective of creating 
actionable intelligence, i.e. information that has been synthesized, analyzed, evaluated, and 
contextualized.  
Rouach and Santi (2001) defined it as the “art of collecting, processing and storing 
information to be made available to people at all levels of the firm to help shape its future and 
protect it against current competitive threat: it should be legal and respect codes of ethics; it 
involves a transfer of knowledge from the environment to the organization within established 
rules”. They also attempted to summarize the various aspects of the Competitive Intelligence 
concept as shown in Figure 1. 
 
Figure 1 - Aspects of Competitive intelligence (source: Rouach and Santi, 2001) 
Their approach categorizes different types of competitive intelligence. First the market 
Intelligence, which is needed to provide a road map of current and future trends in customers’ 
needs and preferences. The second category is Competitors’ Intelligence, which is needed to 
evaluate the evolution of competitive strategy over time through changes in competitors’ 
structure, new product substitutes and new industry entrants. The last category is 
Technological Intelligence, which is responsible to assess the cost and benefit of current and 
new technologies and to forecast future technological discontinuities. 
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The biggest ambiguity lies between the terms BI and CI. There are some authors such as 
(Lönnqvist & Pirttimäki, 2006) and (Tyson, 2002), who have addressed this issue by defining 
BI as an umbrella concept referring to the analysis of internal and external information 
sources and CI as being one of the several dimensions from the BI.  For Gartner Group 
(2014), BI includes all the applications, infrastructure and tools, and best practices that enable 
access to and analysis of information in order to improve and optimize decisions and 
performance. Also for them CI is a part of BI, which is considered to be the "analysis of the 
enterprise’s marketplace to understand what is happening, what will happen and what it 
means to the enterprise".  
Also addressing this issue, the Institute of Management & Accountants (1996) considers that 
there are 3 levels of intelligence, partially represented by the inverted pyramid on Figure 2.   
 
Figure 2 - Relationship between three types of intelligence gathering 
For them, the broadest level of intelligence is BI, which includes CI but also environmental 
scanning, market research and analysis. The CI level comprises all the information about the 
competitors and the competitor analysis is a narrow focus on an individual competitor profile, 
which is understood to be "a package of information about a specific competitor at a specific 
time, that typically includes an overview of a competitor, its key executives, important 
markets and product lines, underlying operations and technology and financial performance." 
(Institute of Management & Accountants, 1996)   
As it can be perceived from the above review of the different definitions of CI, all of them 
refer to a process or framework that comprises gathering, dealing and working with 
information transforming it into intelligence that can support and be useful to decision-taking 
processes. The main difference between the concepts is the scope of the term CI, i.e. to which 
company´s functions should CI be related. Therefore, the terminology and scope of 
Competitive Intelligence efforts in organizations "should be determined on a case-by-case 
basis both in terms of contents as well as the decision-making levels it is primarily intended to 
serve" (Global Intelligence Alliance, 2004) . 
2.3. State-of-art 
2.3.1. How competitive intelligence is being performed 
According to statistics, in the top 500 enterprises of the world, over 90% of the enterprises 
have established CI systems. However, many of these undertaking CI do so at a very low 
level of commitment and intensity and even when a more developed CI project is running, it 
receives few resources (Murphy, 2005). In general, companies established in more 
competitive industries tend to have more CI personnel (Viviers & Muller, 2004).  
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Many ways of approaching the task of undertaking and delivering CI are being adopted. In 
some cases, it is given to an employee as one of several duties or as his sole duty. Less 
frequently, a distinct CI unit is formed. It is also common that companies assign the activities 
related with CI to external consultants, while in others cases, where CI plays an important 
role, and is assigned high priority such as in Procter and Gamble, a director takes charge of a 
CI unit and reports direct to the chief executive officer (Murphy, 2005).  
The survey conducted by Competitive Intelligence Foundation (CIF) answered by 520 CI 
professionals and by GIA indicates that CI is often a small function conducted by people who 
work part-time on CI (Figure 3). 
 
Figure 3 - Percentage of employees' work time dedicated to CI 
Both studies found that in general CI is conducted by a specific division in a company and 
that it makes use of additional support from other company divisions.  
In terms of its structure, CI is most often either a stand-alone unit or a part of marketing or 
market research. Other divisions where CI is often located or to which it reports include 
strategic planning, information services or business and product development (Muller, 2009). 
In large companies CI is more usually performed in-house, although some areas of it are 
outsourced (Global Intelligence Alliance, 2004). As the SCIP report revealed, more than 50% 
of all CI professionals outsource some part of their CI activities. One of the reasons that leads 
companies to outsource CI activities is reducing costs by contracting out services and 
activities traditionally provided in-house and to gain a competitive advantage by seeking 
differentiation and efficiencies (Juha & Pirttimäki, 2005). Furthermore it allows companies to 
focus on their core-business and it ensures that ethical and legal guidelines are followed 
(SCIP, 2014). However, outsourcing intelligence activities comes along with risks that 
companies should be aware of, such as revealing strategies to competitors or confidentiality, 
and provide information to outsiders that can use this information in a way that can be 
prejudicial to the company (Juha & Pirttimäki, 2005).  
 
2.3.2. CI objectives and techniques 
Intelligence activities have a wide range of possible goals. Powell and Allgaier (1998) 
conducted a survey with more than 200 members of SCIP from different industries, that found 
that the objectives of the companies' CI activities tend to be more strategic than tactical, and 
more oriented towards market and competition than sales, as shown in Figure 4.  
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Figure 4 - Intelligence Objectives (source: Powell and Allgaier ,1998) 
They also discovered that the techniques currently used to analyze the information vary 
widely. The top three techniques relate to the development of competitors´ profiles, financial 
analyses and SWOT analysis.   
The companies inquired considered SWOT analysis to be the most effective technique (see 
Figure 5). The more complex techniques such as conjoint analysis and simulation models 
were considered less effective, because they are less understood than other more simple and 
intuitive techniques. 
 
Figure 5 - Usage and rated effectiveness of information analysis techniques (source: Powell and 
Allgaier ,1998) 
Similar results were obtained in the (Competitive Intelligence Foundation, 2006) survey, 
where Competitor analysis and SWOT analysis were the techniques most used by the 500 CI 
practitioners that participated in the study. 
2.3.3. Global CI Overview 
Although there are some studies within countries and others comparing countries with others 
with respect to their CI activities, there is a relative lack of empirical research in field of 
global CI (Blenkhorn & Fleisher, 2007). 
 Rouach	   and	   Santi	   (2001)	   did a study to access the CI activities in French and American 
companies and in which they have identified five types of analysts’ attitudes towards CI. as 
reported in Table 1. 
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 Table 1 - Five type of CI attitudes  
Type	   Description	   Corporate	  examples	   Methods	  
Sleepers	   Have	  no	  deliberate	  CI	  activity	  and	  are	  led	  
by	  passive	  managements	  who	  believe	  that	  
they	  already	  know	  all	  they	  need.	  
N/A	   Blind	  and	  passive	  
Reactive	   Have	  no	  regular	  CI	  operation,	  but	  will	  be	  
provoked	  into	  undertaking	  some	  ad	  hoc	  CI	  
exercises	  when	  faced	  with	  an	  overt	  
competitive	  challenge.	  
Most	  of	  the	  French	  
small	  and	  medium	  
enterprises	  (SMEs)	  
Reacts	  to	  attack,	  
very	  limited	  
budget	  
Active	   Companies	  with	  an	  active	  approach	  have	  a	  
permanent	  CI	  function	  and	  try	  to	  anticipate	  
opportunities	  and	  threats	  rather	  than	  
respond	  to	  them	  when	  they	  become	  
prominent.	  	  
Many	  large	  French	  
firms	  and	  some	  
French	  SMEs.	  Most	  
of	  the	  American	  
SMEs.	  
Limited	  resources,	  
beginning	  of	  
operational	  CTI	  
network	  
Assault	   Have	  a	  very	  pro-­‐active	  management	  of	  CI	  
and	  continuously	  on	  the	  look-­‐out	  for	  
opportunities	  
Ericsson,	  L’Oreal,	  
France	  telecom,	  
Airbus	  and	  IBM	  	  
Significant	  
resources,	  
professionalism	  
and	  ethics	  
Warrior	   Also	  pro-­‐active	  and	  the	  intelligence	  analyst	  
are	  frequently	  ex-­‐military	  intelligence	  
specialists.	  
Thomson	  CSF,	  
Nestlé,	  Cegetel	  and	  
Ford	  
Sophisticated	  tools	  
and	  significant	  
resources	  
They found that most of the French Small and Medium Enterprises (SMEs) are on the 
reactive category and most of the American SMEs and many French large companies are on 
the active category.  
On another study, Wright et al. (2002) analyzed a set of UK companies regarding their CI 
activities and found that the majority perceived CI as "simply knowing about their 
competitors". And while most companies rely upon general and specialist publications to 
provide their research material only a few others do some primary research. These authors 
have also developed a typology of attitudes and practices based on the results from the study, 
presented on Table 2.  
 
Table 2- Typology attitudes and practices of CI  
Type	   Description	  
Immune	   These	  companies	  were	  not	  interested	  in	  their	  competitors,	  believing	  
themselves	  too	  big	  or	  too	  little	  or	  too	  special	  for	  it	  be	  worth	  engaging	  in.	  	  
Task	  driven	   Ad	  hoc	  CI	  activity,	  more	  usually	  carried	  out	  by	  individual	  departments	  than	  by	  
the	  company	  as	  a	  whole.	  Such	  companies	  are	  similar	  to	  the	  reactive	  category.	  
Operational	   These	  companies	  were	  trying	  to	  understand	  their	  market	  environments,	  
although	  their	  CI	  efforts	  (which	  are	  usually	  under	  the	  auspices	  of	  senior	  
management)	  were	  focused	  more	  on	  the	  current	  situation	  than	  on	  taking	  
long-­‐term	  factors	  into	  account.	  They	  resemble	  the	  active	  group.	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Strategic	   Sponsored	  both	  at	  top	  management	  level	  and	  by	  departments,	  the	  CI	  
program	  is	  broad	  in	  scope	  and	  its	  timeframe	  extends	  beyond	  immediate	  
conditions	  and	  concerns.	  
 
Blenkhorn and Fleisher (2007) analyzed and compared Brazilian and North American 
companies and found that North America is executing CI activities better than the Brazilian 
companies (ANEXX D)  
2.4. CI Process 
Kahaner (1997) believes that CI works better as a process instead of a function, arguing that 
the structure of the CI cycle is clearly a process and that having CI working as a function can 
led to the perception of CI being as an “executive spy agency”. This may lead the other 
employees being less participative and contributing less to the CI activities. Global 
Intelligence Alliance (2004) also has the opinion that to have an effective transformation of 
information into actionable intelligence, it is required a process perspective "given that a 
continuous chain of action is required". The core objective of this process is to “turn raw 
information or data into intelligence" which is illustrated by the intelligence pyramid (see 
Figure 6) (Kahaner, 1997). 
 
Figure 6 - The intelligence pyramid (source: Kahaner, 1997) 
In order to accomplish this, the literature has several proposals for CI processes, which 
typically differ in the number and type of stages and characteristics. Most of the models 
adopted by the authors have five stages in common: Planning, collection, analysis, 
dissemination and feedback.  
Recently, Pellissier, R. and Nenzhelele (2013) developed a proposal of an universal process 
model for CI. After reviewing the current literature about CI processes they identified the 
common and unique phases and characteristics used by different authors, which are stated and 
described on Table 2, based on various authors definitions. 
 
 
Table 3 - Common Phases and Characteristics in the literature 
Phases and 
Characteristics  
Description 
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Establishment 
of CI needs 
Identified with different names among the scholars such as “intelligence 
requirements and determination of key intelligence topics”, ”understanding 
the need” and  “defining CI demand”, this phase involves identification of 
the intelligence needs of decision-makers (Pellissier, R. & Nenzhelele, 
2013) and it is in this phase that is determined what CI unit should research 
and to whom (Strauss & Toit, 2010). Upon the understanding of the user´s 
need depends the success of the whole process (Rouach & Santi, 2001). 
(Global Intelligence Alliance, 2004) considers that effective intelligence 
processes set the intelligence users as the starting point for the entire 
function.  
Planning and 
direction 
For some authors this is the first phase, where they integrate the previous 
phase of identifying the intelligence needs in here. (Murphy, 2005) 
described the planning phase as “the management process through which 
intelligence users table requests for intelligence and where strategies for 
satisfying these needs are decided and resources for the activity are 
allocated.“ He further states, that it is challenging prioritizing the so many 
areas potential interest that usually emerge. To deal with that, CI operations 
must be guided based on accurately defined key intelligence needs (KITs), 
which are those topics identified as being of greatest significance to the 
primary users of the CI (Bose, 2008). And these must most of the time been 
determined by the CI analyst, since managers do not always know what 
they really need (Viviers & Muller, 2004). 
Information 
collection  
Being the second or the third phase of the CI process for some scholars, it 
can be referred to in different ways: “data collection”, collecting raw data”, 
“collection” or “gathering”. This phase involves actual gathering of raw 
information and all available ways and methods to collect the information 
from all possible and available sources are identified (Kahaner, 1997). The 
emphasis is on collection of publicly available information, where the 
information to be collected must be relevant to the KITs (Pellissier, R. & 
Nenzhelele, 2013). Sources are usually categorized into primary sources or 
secondary sources (Bergeron & Hiller, 2005), where the first consists of 
direct observations, reverse engineering or human intelligence networks 
(such as employees, clients, competitors, consultants, etc.). Examples of 
secondary sources are internet sources and media. Most of CI analysts 
consider that the most forms of primary and secondary sources are 
important to their CI practice, although results showed that secondary 
sources continue to be a main source of information (Muller, 2007). 
Furthermore, a previous survey showed that about 90% of competitive 
intelligence could be acquired from the Internet (Teo & Choo, 2001). 
Information 
Processing 
Some experts consider this phase as being a part of information collection 
phase. This phase involves processing the information so that it can be 
sorted and communicated (Kahaner, 1997). This means that it is 
responsible to organize, systemize, implement and maintain a mechanism 
of capturing and storing information (Pellissier, R. & Nenzhelele, 2013). 
Depending on the level of decision making involved, the requirements for 
this phase may change. The higher the decision-making level, the more 
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sophisticated the processing required (Global Intelligence Alliance, 2004). 
Information 
analysis 
(Viviers & Muller, 2004) consider this as the core phase of CI process, 
whereas (Kahaner, 1997) considers it the most challenging and difficult 
part of the process, because it “requires the analyst to weigh information, 
look for patterns and come up with different scenarios based on what he 
has learned. Out of the complexity, confusion and uncertainty the analyst 
has to produce a output that should be the options and recommendations 
emerging from the analysis that facilitate senior managers’ strategic 
decision-making”. As (Rouach & Santi, 2001) explain, it is in this core 
element of the process, that seemingly unconnected information is turned 
into intelligence. A survey conducted by SCIP and another one by 
(Competitive Intelligence Foundation, 2006) showed that the most used 
techniques by CI professionals to analyze information are competitor 
analysis or profiling and SWOT analysis.  
Intelligence 
dissemination 
The specialists refer to this phase in several manners, such as 
“communication”, “intelligence dissemination”, “disseminating 
information” or “communicating the finished intelligence” (Pellissier, R. & 
Nenzhelele, 2013). For (Kahaner, 1997) this is the most important part of 
the CI process, because it is here where the most of projects fails. The 
analyst is supposed to present and defend his conclusions and analysis 
based on the raw data he collected. The main goal of the intelligence 
dissemination phase is to summarize the information in a way is readable 
and comprehensible and communicate it to the end-user. It can be preceded 
in many different ways depending on the particular needs of the target 
audience. This can range from a short conversation to a formal presentation 
with slides and supporting documentation (Murphy, 2005). In a survey 
conducted by CI Foundation was found that the communications methods 
used to communicate the product of CI activities included e-mail, printed 
reports and presentations briefings, where e-mail was by far the most 
popular communication method of communicating intelligence (Muller, 
2007). 
Taking action In this phase is where the end-users of the intelligence make use of the 
intelligence produced to influence their decisions and give feedback about 
new intelligence needs (Botha & Boon, 2008). (Global Intelligence 
Alliance, 2004) identifies the main targets for the intelligence’s utilization 
as being: identifying new business opportunities, sharing ideas, improving 
the organization’s ability to anticipate surprises, improving managers’ 
analytical skills and integrating diverse ideas. 
Process and 
structure 
In the literature is often mentioned that in order to have effective and 
productive CI activities it is required appropriate policies, procedures and 
infrastructures (sometimes informal) (Kahaner, 1997; Murphy, 2005; 
Pellissier, R. & Nenzhelele, 2013).  
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Skills 
development 
Embedding competitive intelligence and employees that know the rationale 
for the CI program is a condition for successful CI activities. And for that it 
is necessary considerable training throughout the organization, for which 
the skills development phase is intended. Employees need education about 
possible sources of information that exist and about how to communicate in 
order to make the CI process work. (Pellissier, R. & Nenzhelele, 2013).  
Organizational 
awareness and 
culture 
A company should have awareness of its CI programs and the importance 
of it. It´s crucial to have that and a culture that contributes to a "firm-wide 
CI“. This can be achieved by encouraging and facilitating the contribution 
of all organization’s members that are valuable intelligence agents. 
(Murphy, 2005) says that 70 to 80 percent of the intelligence needed by a 
company resides with employees, who collect it in dealings with suppliers, 
customers and other industry people. So there is a need to motivate these 
employees contribute to the intelligence effort and pass along important 
information. To motivate their employees companies usually have 
incentives such as feeding back information (through newsletters, e-mail or 
competitor information bulletin boards), awards to employees who have 
contributed vital market and competitor information to managers (Institute 
of Management & Accountants, 1996).  
Feedback This is the phase where the users of the intelligence provide their feedback 
about the CI process (Pellissier, R. & Nenzhelele, 2013). (Rouach & Santi, 
2001) suggest that in this stage of the process a deep evaluation of the 
system must be made. (Institute of Management & Accountants, 1996) 
states that it is also important to evaluate the extent to which CI is being 
used in critical management decisions. 
In order to understand the importance and adherence of each of these phases, the frequencies 
of adoption and characteristics were also calculated (ANEXX G). And based on the literature 
and the analysis of the frequencies Pellissier, R. and Nenzhelele (2013) formulated a universal 
CI process model illustrated in Figure 7. This is viewed as a continuous cycle of interrelated 
phases, where the output of one phase is the input of the next phase.  
 
Figure 7 - Propose of universal CI process model 
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This model starts with the phase "planning and direction", that incorporates one crucial 
activity of the CI cycle: establishment of CI needs. The second phase is called "information 
collection", in which information relevant to the KITs is collected. Because the authors 
consider the "information sorting capturing and sorting", also known as information 
processing, as being crucial for the CI activities, this part of the process was considered to be 
a different phase of information analysis, although some scholars considered it as being part 
of the same phase of the cycle. It is important to note that the name "information sorting 
capturing and sorting" was given to this phase in order to eliminate confusion between the 
information processing and the information analysis phases. Since most scholars had an 
"intelligence dissemination" phase in their model, the authors have also incorporated this 
phase in their model as the last one, in which the information is supposed to be disseminated 
to the end-users of intelligence. Fewer specialists adopted the skills development, process and 
structure, organizational awareness and culture and feedback as phases, but in this model they 
were integrated as being influential factors affecting the cycle.  
2.5. Performing CI 
2.5.1. CI analyst 
One key piece of the process of intelligence production is the CI analyst. His/her role ranges 
from looking what is happening in the industry and being able to alert for potentially 
important events to gather information about a specific topic (Rouach & Santi, 2001). CI 
activities are conducted under a complex, confuse and uncertain environment as every 
business environment. So, it is important that the analyst is passionate and persistent about 
what he/she is researching and is able to remember and fit what he/she reads into the context 
of an overall big picture, but also to attend carefully to fine details (Murphy, 2005).  
Decisions-makers, like chief executive officers and senior managers, need intelligence to 
make decisions, but usually they don´t have time to execute CI activities. So they have to 
delegate this task to CI analysts. Therefore one of the factors that leads to a satisfactory CI 
output is a properly briefed analyst, that is aware of the strategic thinking of the decisions-
makers so that he can judge what kind of intelligence should be passed or not to them 
(Murphy, 2005). This is crucial because one common mistake of a CI analyst is to produce 
irrelevant material or intelligence, usually caused by the wrong understanding of the 
requirements of end-users. “It is also very important to separate the "nice-to-know" from the 
"need-to-knows" information. During the research and collecting phase, the analyst will pass 
through a great amount of information and one thing that characterizes a good analyst is the 
availability of ignoring that information that seems to be important, but has not a purpose for 
the needs it is been searched” (Carr, 2003, p. 177). 
Most of the times, CI activities involve trade-offs between time and quality. Analysts often 
believe that a detailed and extensive report is the best way of showing their value, whereas 
most decision-makers seem to prefer a timely answer to a totally accurate answer (Murphy, 
2005). The Competitive Intelligence Foundation (2006) argues that only 70% of the delivered 
intelligence needs to be totally accurate if it is delivered on time (Competitive Intelligence 
Foundation, 2006). Thus, an analyst has to know when to stop the research and therefore have 
the right feeling of knowing if it will be possible or not to get the information it is looking for 
(Murphy, 2005). 
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Furthermore, as Breeding (2002) argues, the main activities that a CI analysts perform are 
answering ad-hoc requests, in which are typically included the following items: 
“demographics and statistics, company financial comparisons, journal and news article 
searches, markets overview, investment analysts’ reports, studies and research reports, 
competitive information international business research,  among others”. Examples of these 
ad-hoc requests from managers that can range from request of the type: “We are competing 
against this firm. Can you tell me all the information you have about this specific business 
segment of them?” to “We are in Egypt and we’re considering partnering with a small local 
company and we need information that company and that market”. Breeding (2002) called 
these ad-hoc requests as reactive requests, where the analyst has to do research to answer 
them. On the other side of the spectrum are the proactive requests, for which the analyst 
already has the answers before the request is made. And one of the goals of the CI analysts 
should be to automate the most common requests for information, and minimize the reactive 
research by transforming them into proactive requests and therefore freeing up time for the CI 
analyst to perform high value-added activities (Breeding, 2002).  
At last, there is another dimension of CI that must be addressed: the ethics dimension. 
Although most of the information the analyst will need is in the public domain (80% 
according to Rouach and Santi (2001)) and will not infringe upon any laws or personal ethics, 
it is important that before starting to gather and store information, the practitioners of CI are 
aware of the legal boundaries, in order to access the information in a scrupulously legal and 
ethical manner (Murphy, 2005) 
2.5.2. CI activities  
Industry analysis  
Industry analysis helps to understand forces that are economically impacting players in an 
industry, as well as the markets in which the company competes (Lewis, 2014). The literature 
suggests the organization shouldn´t just focus on its products and internal processes, as these 
two components alone do not enable any long-term competitive advantage (Jenster & Søilen, 
2009). In order to gain this competitive advantage, a company needs to have a strategy that 
creates a unique and valuable position (Porter, 1985). To be able to achieve this strategic 
positioning, it is essential for an organization to understand the industry´s underlying 
structure, react quickly to opportunities and threats, as well as be aware of its external 
environment, such as its competitors and costumers (Global Intelligence Alliance, 2004). 
Moreover, the development of a robust and sustainable strategy that will enable a superior 
performance through gaining competitive advantage is what ultimately drives all intelligence 
activities. To achieve this competitive advantage an accurate industry analysis is essential, 
because it will provide an awareness of the external environment that will enable to better 
understand the competitive landscape and will enable the organization to better interpret other 
type of information gathered, such as the behavior of a competitor, that can only be fully 
understood if the context in which it operates is perceived first (Jenster & Søilen, 2009). 
Focus on competitors 
Analysing the competitive environment and anticipating competitors’ actions and reactions is 
crucial to formulate competitive strategies (Day & Reibstein, 2004). Figure 8 illustrates the 
scope of competitor intelligence, which is intended to be an important part of CI. 
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Figure 8 – Competitors intelligence scope (Pirttim, 2007) 
Strategic success depends heavily on the strategies of competitors and there are often 
strategies interdependencies between rivals in the same industry. Therefore, the ability to 
anticipate the competitors’ strategic moves is crucial to a company’s success (Courtney, Horn, 
& Kar, 2009). By analyzing capabilities, vulnerabilities and intentions of the competitors, the 
intelligence produced during CI activities allows a company to remain competitive and 
improve performance against its competitors by enhancing the strategic decisions (Bose, 
2008). Furthermore, it enables the companies to develop effective defensive positions over its 
competitors (Porter, 1985).	  	  	  
Company profiles  
Company profiles are usually developed about competitors, but as West (2001) argues, this 
technique is also valid for other purposes. Company profiles are also conducted to monitor 
competitors, potential competitors, indirect competitors and companies that are active in 
related business and might enter in our business (West, 2001). Maintaining the contact with 
these three different types of competitors or potential competitors is important, since it 
enables to address current and future competition. Indirect competitors are important because 
of the effect they can have on the market and also because at any time they may turn into 
direct competitors by broadening their product portfolio (West, 2001).  
Another type of companies that must also be monitored are the companies that are neither 
direct nor indirect competitors, but have the skills and resources to diversify and enter in our 
market (West, 2001). An example of these companies in the Healthcare IT industry are 
companies that offer IT solutions to other industries, but that can at any time use their skills to 
build solutions to the healthcare industry.  
Murphy (2005) explains that a company profile must give a good understanding of how a 
company operates and should offer clues as to its future behavior and performance. To 
achieve this while analyzing a company, the analyst should focus on the present situation as 
well as changes over time, like trends in firm´s financial situation and performance or shifts in 
the markets it serves in terms of region and product portfolio. He/she should also enumerate 
some items that might be addressed in a company profile: background, activities, markets, 
financial condition, financial performance, premises, inventory, technology, R&D and 
equipment, management and ownership, human resources, intangible assets and litigation, 
alliances, company’s external environment (STEEP analysis), SWOT analysis, role and status 
of individuals within a company and their interrelationships (Murphy, 2005). 
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3. Competitive Intelligence Framework Project 
3.1. Competitive Intelligence in the BD International department 
The BD international department is responsible for the inorganic growth of the HS division, 
and therefore it is responsible for all investments and divestures decisions, as well as for 
strategic decisions in all the countries where Siemens HS is present, excluding the U.S. 
Decisions have usually to be made in a very short period of time. So, a quick intelligence 
producing process about specific markets, industries, competitors or costumers is essential for 
the decision-taking process of the department. During the project, the author was in charge for 
most of this intelligence producing process, which usually is triggered by a request from a 
manager about specific information he/she needs to access. A great part of the work 
performed during the internship can be considered as a CI related work, since it perfectly 
matches the definitions of CI activities presented before.  
Almost all the tasks executed in the BD department were in the domain of industry analysis. 
As the healthcare IT industry is evolving rapidly – with a changing environment in terms of 
competition, products and regulations – it is fundamental to the managers and to the CI 
analysts to have a good understanding of the industry and to be aware towards which 
direction the industry is moving. Consequently, during the project researches related to 
industry analysis have ranged from macro researches to very specific studies about small 
entities of the industry. Examples of macro industry studies conducted during the project are: 
research about life-sciences trends, healthcare-related business models, trends of private-
equity firms’ investments in the life-sciences industry and analysis of the healthcare systems 
of different countries.  Regarding the industry analysis with a narrower scope, the major 
intelligence activities conducted were company profiles and competitors analysis. Since the 
BD department is responsible for all M&As, it is understandable that a great part of these 
company profiles developed had the final goal to analyse companies that might be candidates 
for future acquisition, investment prospects, potential partners in a specific project or a threat 
to the business development of the HS.  
The information contained in the company profiles developed were usually divided in 4 parts: 
• Company overview (headquarters, type of company, number of employees, affiliates 
companies, operating regions and segments);  
• Financial information (revenues, profits and margins evolution, financial ratios, sales 
by regions and segments among others); 
• M&A and strategic partnerships activity (information related with acquisitions, 
mergers, divestures and joint ventures); 
• Product portfolio; 
Of course that these criteria have varied from company to company. The decision of what to 
include was evaluated for each case, taking into account the manager needs, the type of 
company and the deadline for the project. Frequently, time was the most important factor and 
therefore a quick profile was developed. In other occasions, when a more detailed research 
about the company was needed, an extensive report about the company was produced. 
Although all type of intelligence was produced during the internship – market, costumer, 
industry, competitor and corporate related intelligence - a major focus was given to 
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competitors’ intelligence and related activities, since the department, because of its functions 
and mission, has a major focus on this type of intelligence. 
The main project developed for the company, presented in this chapter, is totally focused on 
competitors and consists on a framework with the goal of creating a platform to store and 
disseminate information gathered about the competitors. It provides the end-user a 
comprehensive overview of the competitor regarding the markets where it is entering and 
operating as well as the type of costumers it is acquiring or losing. To accomplish this a 
database containing information about wins and losses (WL) of the competitors was created. 
Typically a WL analysis identifies customers’ perceptions of specific products from the 
company and from competitors, providing insights about why the customers are buying or not 
our products or services. These insights can then be actively used to focus sales staff more 
effectively in the marketplace and also to guide the research and development department 
(Fleisher & Wright, 2009). However, because in the specific case of the project, the 
manager’s needs were more focused on obtaining information about the market, the WL 
related information gathered focused more on the regions and type of costumers from the 
competitors, than on the costumer feedback´s about the products.  
Also, information about the M&A activity and strategic partnerships from the competitors 
was gathered in the platform. This type of information is important to track the competitors’ 
M&As paths, in order to assess the emerging build-up of market positions and competencies 
(Jenster & Søilen, 2009).  
With the same purpose of assessing the competencies and market positions as well as being 
aware of recent important moves of the competitors a third type of information was provided 
to the user: relevant latest news about the competitor.  
At last, by developing the CIF, it was also intended to follow the theory best practices and 
transform the reactive requests about competitors into proactive requests by automating the 
analysis of competitors’ data in a way that every time a manager requests information about a 
competitor, the analyst already has the answers in the framework and doesn´t have to start the 
CI activity from scratch.  
3.2. Introduction to the project 
The Project consists in the development of a new CIF specifically for the BD international 
department. It is meant to ensure a structured and formal way of organizing specific 
information and knowledge regarding the competitors (Figure 9). This framework is 
comprised by an Excel file containing three databases with relevant information about the 
competitors, and presents the information contained in the databases through a dashboard in a 
way that is possible to the user to have an overview over the competitor that is analyzed.   
The key part of the framework is the CI analyst, who is in charge of updating, managing and 
monitoring the framework. In order to keep the databases updated and to promote the 
efficiency of the process of gathering data and updating the databases, as well as to enable the 
responsible for the CIF to know how to work and modify the structure of the Excel file, a set 
of support documents was also created.   
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Figure 9 - CIF’s architecture 
3.3. Goals of the CI framework project 
The need of developing a competitor-monitoring tool was triggered during a competitive 
worldwide analysis. This analysis was supposed to analyse the competitive landscape, i.e. 
where, in the entire world excluding U.S., were the main competitors winning and losing new 
contracts and in which context. The stage of data gathering has revealed great difficulties 
because of several reasons. The first has to do with the language - in some countries the 
results of the tenders are published in the country's language. Second it is hard to access non-
recent information - it tends to disappear or to get more difficult to access as time passes by. 
Third, it is very difficult to have access to the right amount of information in a short period of 
time, as the present situation demanded.  
So, in order to overcome these problems and to automate CI activities that are usually 
required to answer the managers` need, an implementation of a CI framework that would 
support an on-going process for gathering this type of information was needed.  Furthermore, 
another management requirement was that the platform should provide a big picture of the 
main competitors, i.e. relevant and complete information about the competitors.  
So at this point it was clear that the goals of the project were to create an on-going process of 
collection and storage in a coherent way, relevant information about competitors. The 
framework to support such process, should help to quickly disseminate the information to the 
users, whenever information about competitors required.  
The information storage and dissemination was made in Excel because it is an application 
widely used. Moreover, the use of Excel would enable the managers to interact and use the 
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information easily, and it would also be easier for the future managers of the platform – intern 
of the department – to administrate it. In addition, the managers preferred to use Excel for this 
project, because the department is small (composed only by 4 employees) and the share of 
information is usually done by email or by storing files in a share folder.  
3.3.1. Methodology 
The deployment process of the CIF was based in the universal model presented in the 
literature review. So every time it was possible, the phases and the ordering previous 
presented were adopted, as well as the best practices suggested by different authors in the 
literature for the implementation of each phase (Table 3). 
Planning and direction Phase 
At this stage, it was already known that one goal of the project was the implementation of a 
continuum process in order to gather the information that tends to disappear over time, and 
also to have available updated information about competitors. A crucial factor of the process 
was to determine the KITs. Together with the department experts, it was concluded that the 
framework should provide an overview of the business development of the competitors. In 
order to achieve this it should be tracked and analysed three type competitors´ movements: 
industries in which they operate; regions where they are entering or leaving; acquisitions or 
loss of new costumers.  
In addition, the framework should be developed in a way that would be easy for anyone to use 
it and to administrate it, which includes updating the databases and also to revise its structure 
in case it is desirable. In order to reach this, several support documents (how to best gather the 
data, description of the excel file components and how to use it and change them) were 
created. Furthermore a tutorial about how the platform works was included in the "intern 
guide" (the document that supports the transaction from one intern to the next one). This was 
made, because it was intended that the platform would be managed, updated and configured 
by the intern of the department - which is supposed to change every 6 months. 
Information collection 
Before starting to gather the raw information, it was necessary to outline exactly which 
information would be relevant to the KITs and from which sources it should be collected.  
After consulting the opinion of some experts and potential users of the platform, it was 
concluded that to keep track of the rivals' movements and the dynamic in the HIS market, the 
information needed would be about the WL from the competitors, their M&A and strategic 
partnerships activity and relevant news about them.  
A great part of the information was obtained through the Internet and most of the relevant 
sources were uncovered only after spending an extensive amount of time searching on the 
Internet. Having identified the importance of these hidden sources of information and the best 
methods to get the desired information, a document whose aim would be to support the 
management and update of the CI platform was produced. This way, it was safeguarded that 
the next person that updates the databases can easily and in a more efficient way have access 
to the information. One of the goals of the support documents is to promote the enhancement 
of the information gathering that can only be achieved if every CI analyst who uses the 
platform shares his knowledge with the next ones, about how to best and faster gather the 
information. 
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The phase of collecting information was the most time consuming phase, since the 
information needed wasn´t available in a way that was immediately recognized and therefore 
it was required to dig deep into the sources - documents, news and articles - to extract only the 
relevant information. Besides that, it was only noticed in a later stage that some more specific 
information was needed, which required an additional iteration of gathering information. For 
the WL database a total of 360 records regarding 9 competitors and from 46 different 
countries were collected. For the M&A and strategic partnerships database a total of 750 
records from the same competitors were collected, processed and stored. 
Information sorting, capturing and storing and information analysis  
Both phases, information analysis and information sorting, capturing and storing, were 
addressed together in this particular project. This happened, because the aim of the project 
was not to produce insights or recommendation about the information gathered - what is 
supposed to do in the information analysis phase - but to provide a framework that presents 
the complex and vast amount of information in a simple and fast way. Besides that, it is 
difficult to clearly separate the activities that belong to one or another, since efficient storing 
and segmentation of information is needed to produce a good analysis and analysis trials are 
also needed to achieve and understand the best storing structure of the information.  
Therefore, this phase was comprised by an iterative cycle starting with storing and sorting the 
information, trying to come up with relevant analysis, realizing what segmentations or data 
were missing and going back to the information gathering phase in order to obtain the missing 
information and segmenting the data in a way it would enable to do proper analysis.  
The information was stored in three different databases (i.e. in three different sheets in tables): 
one for the WL, another one for the M&A and strategic partnerships activity and a third one 
to store the information related to news and reviews from the competitors. This way it is 
easier to create a user-friendly excel file, where the user clearly understands where it is 
possible to have access to the different types of data. 
Wins and Losses database 
The WL database was stored with the following attributes (Figure 10): 
• Vendor:  competitors' name 
• Country: country where the record happened 
• Date: date of the record  
• Type: indicates if the record is a win a loss or a loss in tender 
• Costumer: costumer name 
• Costumer type: single-hospital, multi-hospital, non-hospital or ambulatory hospital 
• Nr. of Beds: applicable only to single-hospitals and multi-hospitals when the type of 
system is HIS-related. 
• Description: detailed description of the record 
• Value: value associated to the record 
• Incumbent: vendor of the previous system, i.e. the system that has been replaced 
• Incumbent system: indicates the incumbent´s system installed 
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• Scope: What type of systems and services does the contract involve (HIE, HIS, 
services or any combination of them) 
• Region: East Europe (E.E), West Europe(W.E), Middle East (M.E), Asia, Pacific and 
Africa Collections (APAC) and Americas (excluding U.S) 
Figure 10 shows an example of 3 records of the WL Database and how the interface explore 
the framework looks like. 
 
Figure 10 - Sample records from the WL database 
Each record has an attribute that specifies the country where it happened. Because in some 
occasions it was difficult to analyse segmented by countries, it was decided to create another 
attribute that aggregates information about the countries into regions: Americas (excluding 
U.S.), Middle East (ME), Asia Pacific and Africa Countries (APAC), West Europe (W.E) and 
East Europe (E.E). This made possible to have a clearer view of patterns in the WL from the 
competitors around the different regions.  
The value of the contract of the records is usually not disclosed. So there was the need of 
having an attribute that would enable to quantify the WL. A traditional way used by 
industry’s experts to segment the costumers (most of them hospitals and hospitals networks) 
in the HIS market is through the number of beds, because it is correlated to the value of the 
contract. HISs are usually sold through licences. Each hospital's employee must have a license 
to work with the HIS. And because the number of employees usually depends on the number 
of beds in acute hospitals, the number of beds provides an accurate estimation of the 
costumers' value.  Therefore, in order to have an attribute in the database that gives an idea of 
the record´s value, it was decided to add to each WL registration the costumer’s number of 
beds.  
This approach led to another problem: there are cases where the costumer doesn´t have beds - 
like for example ambulatory hospitals - or isn´t a single-hospital – it can be a hospital network 
- as well as there are cases where the costumer isn´t a hospital at all –for example insurance 
companies. Because of the differences that exist among them, there was also the need to 
characterize the type of costumer for each WL record. This was made by categorizing the 
different type of costumers as single hospital, multi-hospital, ambulatory hospital or non – 
hospital. 
Furthermore, it was noticed that the differences of the contract scope - what type of system 
and services were acquired - related to the WL record should be also registered. This 
distinction is important to be made because the contract scopes can vary from small systems 
installations to big projects with a lot of services attached. To address this issue it was decided 
to add the information about the scope of the contract – HIS, HIE and managed services - 
related to the WL record. 
Besides these sorting of the data, it was also detected that there were two very different types 
of losses: loss of a contract and a loss in a tender (the vendor went to tender against others 
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competitors, but didn´t win the costumer). Obviously, these two types of losses are 
completely different and a distinction had to be made between them. So a third type of record 
- loss in tender - was considered.  
The last possible enhancement to the storage of data identified was related to the incumbent. 
The field incumbent indicates who is the vendor of the system that was installed in the 
customer before the WL, i.e. the system that has been replaced. The problem is that one single 
vendor has more than one system and it´s different to lose a costumer with an old and legacy 
system than to lose a costumer from the latest “go-forward” system. So, in order to enhance 
the analysis of the WL a field regarding the incumbent system was also added to the database. 
Competitors’ News database 
To store competitors’ related news, a separate database was created. The goal of the database 
was to contribute to the competitor overview by providing the latest relevant news at a glance. 
Furthermore, it provides the user with a quick summary about the latest relevant news in the 
industry. By consulting this database, the user can analyse and filter the industry´s and 
competitors' news, but also analyse specific countries' news. For each record the following 
attributes were registered: 
• Vendor: indicates to which competitor is the news related 
• Date: date of the news 
• Title: title or brief description of the news 
• Type: positive or negative news. 
• Link: link to the source of the news 
• Country: country related to the news 
Figure 11 shows a set of records from the database. The idea of only having the title or a brief 
description of the news is to provide the user of the platform with an accurate but short idea of 
the news about each competitor. Separating the news in positive and negative makes it easier 
for the user to extract information from the database that can be useful, for example, to 
conduct a SWOT analysis about the competitor. This distinction is also useful for the 
competitors' summary dashboard that will be introduced later on the information 
dissemination phase.  If the user wants to know more about particular news, for each record 
there is a link button that will redirect the user to the original news source. At last, it was 
considered important to group the news by country, because it´s often needed to conduct an 
analysis about a specific country or competitor´s activities in specific countries.  
 
Figure 11 – Competitors news database 
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M&A activity database 
Based on previous M&A reports produced by the department every quarter, and after 
questioning the managers for their intelligence needs about competitors’ activity in this field, 
it was identified the kind of information considered relevant about M&A deals and Strategic 
Partnerships. The sorting of the information for the database was the following: 
• Vendor: competitor name 
• Date: date of the deal 
• Type of deal: merger, acquisition, sell or strategic partnership 
• Target Company: name of the secondary/target company and a small description 
• Portfolio: description of product portfolio involved in the deal  
• Description: description of the deal 
• Value: value related to the deal 
• Country/Region: In which country or region operates the target company  
Figure 12 shows a part of the M&A database stored as a table in an excel sheet, which enables 
the user to filter and get to know which competitors are acquiring or developing strategic 
partnerships in a specific country or region.  
 
 
Figure 12 - Example of M&A database records 
The information stored in this database is intended to give the user of the platform the 
information about what type of companies are the competitors acquiring, selling and 
developing partnerships with, and that way get an insight about their product portfolio, 
competencies and type of markets in which they are operating.  
Intelligence dissemination 
All the information was stored in an excel file comprised by five sections (five different 
sheets): WL database, M&A database, news database, competitor overview and analysis tool. 
In order to have a user-friendly and easy to use tool, an interface was created to navigate 
through each one of these sections (see Figure 12). 
Databases 
Besides the function of storing the data, the databases allow the user to filter the data in order 
obtain the information they needed. Furthermore, a user that is familiar with pivot tables can 
conduct more sophisticated analysis with the pivot tables feature, and also to develop charts 
based on the data from these databases. 
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Competitor overview section 
The competitor overview section is intended to disseminate  the intelligence about each of the 
competitors. At this section the information from the databases is presented through charts 
and tables, in a way that is easy to the user to have a sense of what are the competitor WL, 
M&A activity and latest relevant news (ANEXX D).  In order to accomplish that, a dashboard 
composed by three parts was created: one that provides the user with general overview of the 
information from the three databases, another one with focus on the wins, and a third one 
focused on the losses. 
In the competitor overview dashboard the user selects the competitor and the years he/she 
wants to analyse, and the information about that competitor is presented. The first part of the 
dashboard - “Overview” - is comprised by a summary of the WL and losses in tenders by 
region and country, a graph containing the other competitor from which the competitor under 
analysis has won costumers, another one containing the competitors for which it has lost 
tenders to, and a last one with the competitors to which the company has lost costumers (see 
Figure 13). 
 
Figure 13 – Dashboard overview 
This tool is supposed to be more focused on the wins and losses from the competitors. 
Because of this, it was chosen to give just a short summary of the information on the 
dashboard: the latest 10 records of the M&A and strategic partnerships, and the five latest 
positive and negative news.  
The second part is devoted to the wins of the competitor under analysis. Here the charts 
present information by year, region and country where the wins took place, and is segmented 
by type and size of the costumers. 
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Figure 14 - Wins dashboard 
The last fragment of the dashboard is similar to the wins part, but focusing on the (see Figure 
15). 
 
Figure 15 - Losses dashboard 
Analysis tool 
In order to have a dynamic and updated dashboard, all the charts are attached to pivot tables 
connected to the databases. If the user knows how to work with pivot-tables, than it can adjust 
the chart to the information he wants to analyse. But one of the reasons to develop the tool in 
Excel was to enable any kind of user to work with it. So, in order to overcome these issues, 
the section “analysis tool” was created. The analysis tool gives some flexibility to choose 
parameters that drive the charts and has also charts where comparisons among all the 
competitors are made (Figure 16).  
Competitive Intelligence and Business valuation in the Healthcare IT industry 
33 
 
Figure 16 - Example of one type of dynamic charts available in the analysis tool 
This section was developed for that users that don´t want to spend too much time on the doing 
the analysis or that don´t know how to use pivot tables. 
3.4. Conclusion and recommendations 
3.4.1. Conclusions from the Framework to the BD international department 
Although a great part of the time available was dedicated to gathering the information to the 
databases, which involved a great effort, it is impossible to have all the data related to this 
topic. Regarding the WL it must be noted that the sample collected is not a good 
representation of the population. There are countries and regions where this type of 
information is easier to access and therefore they are better represented in the databases. 
There are also some competitors whose information is easier to gather, and therefore they will 
have a greater number of records in the databases. So, the user of the framework has to be 
aware of this limitation when conducting analysis about the WL data. To overcome this 
problem, it is recommended to conduct analysis and make conclusions that aren´t affected by 
the fact that the information is incomplete. For instance, to avoid conducting analysis that 
require all the information - or samples that are a realistic representation of the population – 
such as determination of market shares. Second, it is essential that the manager of the 
framework keeps the support documents and the structure updated. One of the main goals of 
the support documents is to implement a philosophy of continuous improvement of the data 
gathering. However, every CI analyst who has contact with the framework should contribute 
to achieve this goal. Along with this, the requirements and the structure of the framework 
should be continuously adapted, since it might happen that the needs, as well as the users, 
change over time.  Every time a potential useful new type of information is identified, the CI 
team should verify with the users if it is relevant to be added to the framework – as a new 
attribute of the existing databases or as a new database. If the department, or the size of 
information contained in the databases grows it should be considered to deploy the CIF in the 
intranet. But to do this is important that the structure and the logic of the CIF is proven to be 
the right one for the long term, since such a deployment would need a big investment.  
At last, there are two gaps in the framework that must be indicated. The first is related to the 
fact that the framework doesn´t address properly the product-related information about 
competitors. The second gap has to do with the valuable internal information that isn´t 
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captured, since the framework only gathers information from external sources. These two 
issues weren’t addressed properly, because the requirements specified for this project and 
because of the barriers that exist in information sharing between departments. Nevertheless, 
they were included in the suggestions for improvements reported to the CI team described in 
the next chapter. 
3.4.2. Suggestion of implementation the CI framework to the HS division 
Because it is believed that the platform developed in this project is more powerful if all 
employees have access to it and can contribute to its improvement a recommendation to adapt 
the CIF to the whole Health Services of Siemens Company was made. Since the CIF was 
developed with the intention to be used only on the BD department, an adaptation of its 
structure to the needs of the group should be done to address the whole HS division properly. 
In the HS division, only recently a CI team has been established to address the CI needs. This 
team is in charge of starting to address CI issues, just by the time the current project was 
ending in the company. This was a disadvantage, because during the project there wasn´t  a 
established CI function to support the project.  
 
Figure 17 - Current CI model in HS division 
The way CI is currently conducted in the HS division is represented in the Figure 17. 
Information is being shared in two ways: through the Siemens Social Network (SSN) or 
through a Competitive Intelligence Repository (CIR) – a file storage location in the internet 
just launched and therefore in an initial stage.  In the SSN a group dedicated to CI was 
created, where employees share news and information about the market, competitors and 
healthcare IT industry. The CÌR is accessed through the intranet and it is where the employees 
can upload and download files related to competitive relevant information. So it is a storage 
location that is intended to be a structure to promote the share of information. To adapt the 
CIF to the whole Health services Division, 2 options were first considered. 
Option A, illustrated in ANEXX G consists in adapting the CIF excel file to the needs of the 
total HS division CI and store it in the CIR so that any employee can download it and use it. 
The file must before be adapted, because the needs of the whole HS division are different than 
the ones from the international BD department. Besides storing the excel on the CIR, a person 
Competitive Intelligence and Business valuation in the Healthcare IT industry 
35 
to manage this file should be nominated, since the databases should be updated on a regular 
basis and should also be updated with the relevant information that is flowing into SSN and 
CIR. 
Option B, the second option suggested to the HS CI team, was to create a competitive 
intelligence platform in the intranet, where the logic adopted in the CIF developed to the BD 
department should be adopted. So it should have a database containing the relevant 
information about competitors and a section where a summary of this information for each 
competitor is presented in a comprehensive way, providing a profile about a specific 
competitor. If it is possible a tool that would enable the user to conduct analysis (Figure 18).  
 
Figure 18 - Option B to adapt the CI framework to the HS division 
Also in option B, it was suggested to nominate a person responsible to manage the 
competitors’ intelligence platform, who should be in charge of scanning all the information 
that is uploaded to the CIR and SSN and that should be added to the competitive intelligence 
database. It was also suggested that the employees should be able to update by themselves the 
competitor’s intelligence database, but in a way that the quality and consistence of the data 
inserted in the databases is ensured. For example by creating an user-interface for the users to 
insert the information in the databases, where it is clear how and what information should be 
introduced. Furthermore, the responsible of the database should be aware of all the 
modifications, for example by being alerted every time a record is added, so that he can keeps 
track of what information is being introduced in the database and who has inserted a specific 
record in the database. This is important because the responsible for the database must be the 
key person who, besides being a resident expert on competitors, must also coordinate the 
competitive information by helping help all the users on consulting and updating the database. 
But more important, since this database will be connected to more functions, departments and 
employees, it should cover a broader scope than the one covered by CIF developed for the BD 
department. Actually, there are two gaps in the CIF that haven´t been addressed properly. The 
first one is the fact that the product-related information – from competitors and from Siemens 
-, such as costumers’ feedbacks and industry experts reviews haven’t been addressed. To 
overcome this, besides the already included in the CIF information, this new platform should 
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cover information that before wasn´t a need or wasn´t possible to access, like product-related 
information.  
The second gap, which somehow is related with the previous one, is that the CIF was almost 
based on external information, i.e. no internal information was gathered. There is a lot of 
information flowing internally. And regarding this, there are experts who argue, that although 
it is not easy as an online search, tapping into the human network from the company can be 
the best source of competitive and market intelligence (Lewis, 2014). (Malhotra, 1996) states 
that despite the increasing sophistication of CI tools and techniques most important role in a 
CI program remains of the organizational or its internal information. 
Everyday employees exchange important information by e-mail, on a conversation or even on 
works they developed to their department. For example, sales teams receive feedback about 
the costumers about their product or the competitor´s products. Managers attend to 
tradeshows where they have contact with industry insiders and sales people and get important 
insights from them. Or even human resources that interview job candidates who work or may 
have worked for rival firms. There are a lot of examples where important information about 
competitors flows and is not been captured and stored in a way it is useful to all the people 
that need to have access to it.  
This new CI platform to the HS division should address this internal information issue by first 
designing a comprehensive structure to store all that relevant information and that is capable 
of producing intelligence from the information contained in it. And second by putting a great 
effort in encouraging all the employees to gather competitive information and to participate in 
the competitive intelligence activities by sharing the information they have. Each one of this 
independent information can help building larger pictures about the competitors.  
The first can be achieved if the information is stored in a way that can be consulted in a 
comprehensive way and fulfils the managers’ needs. And for that it is essential to involve the 
managers and the people that have knowledge about the information that is being stored and 
that will use the platform.  The second can also be achieved if there is an effort from the CI 
team to engage all the employees in participating in the CI process and also to gather relevant 
information from where it is possible. Examples of programs to enhance the engagement of 
the employees that have been given to the CI team are:  
• Rewards to the most actives users, who have contributed with vital market and 
competitor information to managers (Institute of Management & Accountants, 1996) 
• Incentives such as feeding back information through newsletters, e-mail or competitor 
information bulletin boards (Institute of Management & Accountants, 1996) 
• Address personally the employees to inform them what type of information from the 
database could be useful to them and discuss how this employee could contribute to 
the database (Helm, 2011). 
• Conduct workshops on how to use and update the database as well as how is the best 
way to collect competitive information (Breeding, 2002). 
• Involve the high level managers and ask for their public recognition of support to the 
CI activities (Breeding, 2002) 
• Support from the managers in order to overcome barriers between the departments and 
to uncover hidden information. 
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• Build relationships with those who can better contribute to the CI activities and 
storage (Lewis, 2014) 
• Working with the corporate communications group to get CI group and platform 
featured in company literature and newsletters (Breeding, 2002) 
• Use Siemens social Network to make all the employees aware of the existence of the 
CI platform and the information in it 
• Develop key performance indicators (KPIs) about the sharing performance in order to 
create a healthy competitive environment between the employees or departments.  
 
 
 
After analysing the feedbacks from the CI team to both suggestions, a final proposal with a 
roadmap containing four stages of implementation was given to the CI team and HS 
managers. (Figure 19) 
 
Figure 19 - Roadmap to implement a CI platform to HS 
It was suggested that in a first stage the CI team gets to know well the CIF and the way the 
data is stored in it. In this phase the CI team is also supposed to identify possible 
enhancements to it so that the excel file that will be used in the pilot project is adequate to it. 
In a second stage it was suggested to adopt option A – store the enhanced excel file in the CIR 
- to identify the different users’ needs, the potential information it could be stored and to 
conceptualize the structure it should be used for the CI database that will be installed in the 
intranet. Analysing users’ feedbacks and needs after the project pilot with the option A should 
enable to achieve this.  
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As soon as a clear concept and architecture to the CI database to install in the intranet is 
accomplished, the third stage – install the CI platform in the intranet - should be putted in 
place. So, getting from stage 2 to 3 is the same as using option A to identify the best way of 
implementing option B.  
The last stage would be devoted to address the not previously attended internal information 
and to engage all the employees into the CI activities. 
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4. Business Valuation 
4.1. Introduction to valuation 
Knowing the value of an asset and what drives it is crucial to take intelligent decisions. 
Valuating an asset is needed in a wide range of situations, such as to choose investments in 
portfolios, to define the appropriate price to pay or receive in an acquisition, and to decide 
investment choices when running a business (Damodaran, 2011).  
Executing a valuation is not a precise science since the value is driven by a vast amount of 
factors and it depends on the purpose of the valuation as well as by who is preceded (Sjöqvist, 
2008).  As Damodaran (2011) explains, "all valuations are biased, the only question  is how 
much and in which direction". Besides the fact that the analyst has always influence on the 
valuation, there is also the problem that a lot of information provided to the analyst is already 
biased. This must be taken into account during a valuation process, where adjustments and 
corrections should be done whenever it is needed. 
The valuation methods that are most frequently user are: (i) Discounted Cash flow (DCF) 
valuation, an income-based valuation that estimates the value of a business based expected 
future cash flows (CF); (ii) Relative Valuation, a market-based valuation which estimates the 
value of an asset by analyzing the price of comparable assets; (iii) Adjust Book Value 
method, an asset-based valuation that considers the value of a company to be the difference 
between the book value of the assets and liabilities;  and at last, Contingent Claim Valuation, 
that recognizes the value of assets whose cash flows are contingent on a future event 
occurring (Damodaran, 2011; Venema, 2007). 
This master thesis will focus in the DCF and relative valuation methods, since a combination 
of the two was used in the project. Besides, it was also considered that the others weren´t 
appropriate for the type of business to be valuated.  
Adjust book value method has advantages such as the fact that it is simple to use and does not 
require a large extent of assumptions. However, it has the problem of requiring the full access 
to all of company´s internal information and disregarding some qualitative factors, such as 
management talent and non-activated intellectual property rights, as well as it is focused on 
the history rather on the future of the business (Sjöqvist, 2008; Venema, 2007).  Furthermore 
it also has the problem that some important value creators, such as intangible assets, are 
valued in the balance sheet in a way that doesn´t reflect their real value (Moeller & Brady, 
2014). This method is best applied to businesses that are in a great part composed by tangible 
assets, which is not the case for a services and IT business, as most value created is through 
its people, services and software, or to valuate companies that will be liquidated or are 
insolvent (Damodaran, 2011). At last, it must be pointed out that this valuation method is 
legally required in some jurisdictions such as China. 
Contingent claim valuation isn´t often used to value the type of business considered in the 
project, since normally this method is used to value projects with huge risk and uncertainty, 
and where it is difficult to link the value of the assets to future CF. Typical examples for this 
would be the development of a pharmaceutical drug or a search for a new oil field (Moeller & 
Brady, 2014). 
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4.2. Discounted Cash flows Methods  
DCF valuation methods estimate the value of the asset by accessing its capacity to generate 
CFs in the future and the risk associated with these CFs. The logic under it, is that the 
company´s value is determined by the value of the CFs that will be available to its investors in 
the future. So to access the company’s value, the present value (PV) of the expected future 
CFs to investors is calculated. This is made by discounting the sum of expected CF  at rates 
that reflect the riskiness and time value of these CFs4 (Damodaran, 2011; Moeller & Brady, 
2014). Since it is not possible to estimate CFs forever, in practice it is common to divide the 
value of the asset in two elements5: the present value (PV) of expected CF for the explicit 
forecast period and after the explicit period, usually named as terminal value (TV) or 
continuing value (Koller, Goedhart, & Wessels, 2010). 
The DCF based methods have the advantage of being less exposed to market moods and 
perceptions, and also to force the analyst to think about the underlying characteristics of the 
business, what ultimately can lead to capture unique characteristics of the business and lead to 
a better valuation (Damodaran, 2011). Furthermore, it takes into account business related 
value drivers, and allows conducting sensitivity analysis, i.e. to simulate and analyze different 
scenarios. However they require more explicit inputs and information than other valuation 
approach. These inputs are difficult to estimate and can be easily manipulated (Damodaran, 
2011). DCF methods have also the problem that they might not consider important market 
valuations’ insights (Koller et al., 2010). 
4.2.1. Valuation process 
Soffer and Soffer (2009) describe a valuation process model where before the valuation 
method is applied the analyst must go through a set of analysis that will provide him 
information to accurately estimate the required inputs.  
The first phase, related to business analysis, is intended to give the analyst a perspective of the 
internal and external factors that drive the performance of the company (Soffer & Soffer, 
2009). The second phase, named accounting analysis phase, is where the business financial 
reports such as balance sheets and income statements are analyzed and where possible 
adjustments or correction should be identified. The last phase before valuation, relating to 
financial statement analysis, is where the financial data should be compiled and an historical 
and financial profile about the company should be built. In this phase, ratios are calculated 
and analyzed, also including their evolution over the years, in order to give different 
perspectives about the company to the analyst (Sjöqvist, 2008). The insights and outcomes 
from these phases should help the analyst to make an accurate forecast of the company´s 
future economic performance and clarify the inputs and the assumptions that must be made 
(Groves & Knott, 2013; Sjöqvist, 2008). 
Groves and Knott (2013) also points out the need to access the historical performance of the 
value drivers of the company performance, which they consider to be the return on invested 
capital (ROIC) and its ability to growth, in order to place the forecast in a proper context. In 
line with them, Damodaran (2011) suggests to conduct the estimations of CF based on the 
historical performance of the company. He also suggests to do the estimations based in what 
                                                
4  !"#$%  !"  !""#$ =    !(!"!)(!!!) + !(!"!)(!!!)!   + !(!"!)(!!!)! +⋯+ !(!"!)(!!!)! , where r reflects the risk of the expected CFs 
5 !"#$%  !"  !""#$ =   !"  !"!"#$%&%'  !"#$%&'(  !"#$%&     + !"  !"    !"#$%  !"#$%&%'  !"#$%&'(  !"#$%& =    !"!(!!!)! +!!!!!! !"(!!!)!  
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others are estimating to similar firms, as well as to look at the fundamentals of the company, 
i.e. how much the firm is investing in new projects - reinvestment rate - and the ROICs that 
the firm is making for them6. 
4.2.2. DCF models 
 Groves and Knott (2013) consider four possible DCF methods to conduct a valuation (see  
Table 4): 
 Table 4 - DCF models 
Model	   Measure	   Discount	  factor	  
Enterprise	  DCF	   FCF	   WACC	  
Economic	  Profit	   Economic	  Profit	   WACC	  
Adjusted	  Present	  Value	   FCF	   Unlevered	  Cost	  of	  equity	  
Equity	  CF	   CF	  to	  equity	   Levered	  Cost	  of	  equity	  
 
The Equity CF model calculates directly the equity value by estimating the future CFs 
available to equity holders and discounting them at cost of equity. Enterprise DCF, Economic 
Profit (EP) and adjusted present value (APV) valuate the entire business, by discounting 
future free cash flows (FCF) to the whole firm (equity and debt holders) at the cost of capital.  
Groves and Knott (2013) use the last three models to calculate the value of the operations (not 
including the value from non-operating assets7 in the future CFs). After having the value of 
the operations, the value of non-operating assets must be added in order to get the enterprise 
value (EV) (see Figure 20). 
 
Figure 20 - Equity value calculation 
EV is the value of the entire company and therefore it includes the equity and non-equity 
claims. So, the value of non-equity claims8 should be subtracted from the EV to obtain the 
equity value of the company (Damodaran, 2011; Koller et al., 2010). 
                                                
6 By having a good estimation of ROIC and the reinvestment rate, the analyst can make an accurate estimation of growth rate that is given by 
the growth from new investments plus the growth of efficiency of this investments (ROIC).  
7 Non-operating asset is an asset that is unrelated to the core operations such as excess cash and marketable securities.  
8 Non-equity claims among others it includes debt, employees’ options and also contingent claims that should be considered (for example a 
law suit in which the company is involved and that might represent a non-equity claim in the futures). 
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Groves and Knott (2013) argue that splitting the value of the firm in value of operations and 
non-operating assets is useful not only to access the real performance of the operations, but 
also to compare different business units and companies. Besides, they also argue that “having 
a clean measure of operating performance over time leads to better forecasts”. 
4.2.3. Enterprise DCF and Economic Profit models 
Enterprise DCF is also known in the literature as classic DCF valuation. It remains the 
favorite of the experts, “because it relies solely on the CF of the company, rather than on 
accounting based earnings (which can be misleading)". However EP model - also known as 
economic value added (EVA) - is gaining popularity because of its "link to economic theory 
and competitive strategy” (Groves & Knott, 2013).  
Enterprise DCF calculates the present value of operations by discounting the value of future 
Free CF (FCF), which are the CF available to all the company’s investors. To calculate the 
FCF, the following calculations must be performed (ANEXX E): 
1. Calculate the net operating profits (EBITA) less adjusted taxes that represent all the 
CF generated from the operations and known as NOPLAT. 
2. Add back the value of depreciations to NOPLAT 
3. Subtract the invested capital9 to obtain the FCF 
In order to estimate the NOPLAT and invested capital, (Groves & Knott, 2013) suggest on the 
short run to forecast all the financial statements items. On the long run (usually after five 
years) these items become harder to estimate. So, they suggest estimating FCFs on the key 
value drivers like operating margins and ROIC. 
In the EP model the value created during a period is calculated as follows: 
!"#$#%&"  !"#$%&!   =      !"#$%&$'  !"#$%"&!×  (!!"#!   −   !"##!) 
To calculate the PV of the operations, the initial investment is summed to all economic profits 
of future periods discounted at the WACC rate (ANEXX F): 
!"#!!  !"  !"#$%&'!!"  ! =      !"#$%&$'  !"#$%"&! +    !"#$%&$'  !"#$%"&!!!(!!"#!   −WACC)(1 +!"##)!!!!!    
The difference between the two models relies in the fact that in the enterprise DCF model the 
analyst has to forecast the all financial statement items to calculate the future FCF, while in 
the EP model the value created each period is accessed only through the reinvestment, ROIC 
and WACC. Groves and Knott (2013) states that an advantage of the EP model is that by 
calculating the value this way it is possible to analyze the effect that ROIC and WACC have 
on the value and how and when is value created.   
Weighted Average Cost of Capital (WACC) 
Both methods discount the value created to the investors at the WACC rate. The rate at which 
the CFs are discounted is supposed to represent the risk that the investors attribute to the asset 
that will generate these CFs, and consequently reflects what is the reward they require to 
invest in that asset (Damodaran, 2011; Koller et al., 2010). Since EP and classic DCF 
                                                
9 Invested capital is the capital required to the operations such as investments in operating working capital, property and equipment. 
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methods calculate the CFs that are generated to both investors in equity and in debt, the 
discount rate should reflect in a proportional way the expected return of these two types of 
investors. So to obtain the WACC a weighted average - based on the capital structure (debt-
equity ratio) - of the cost of debt (k!) and cost of equity (k!) is calculated as follows10: !"## =      !! + ! k! 1 −   !! + !! + ! k! 
The cost of equity represents the expected return rate for equity whereas the cost of debt 
represents the expected return rate for the debt holders (Damodaran, 2011; Koller et al., 
2010).  
To estimate the cost of equity of public companies the experts use different models such as 
Gordon’s model, arbitrage pricing theory (APT) and capital asset pricing model (CAPM). The 
standard approach is CAPM, since it is the simplest model to use. For private companies the 
cost of equity can be calculated by looking at similar public companies (Damodaran 2011; 
Koller et al. 2010). 
In order to estimate the cost of debt, for public companies (Damodaran, 2011; Koller et al., 
2010) suggest using the yield to maturity (YTM) of the company’s bonds or look up the rating 
of the firm in order to estimate a default spread. If none of these two is available, then a 
synthetic rating should be calculated in order to estimate the cost of debt11.  
Adjusted present value (APV) model 
In the first two models, all future CFs are discounted at a constant WACC. By using a 
constant WACC the analyst is assuming that the capital structure is constant (or managed to a 
target), which actually is applicable to most of the situations, since usually debt grows 
proportionally to the company value.  But in some cases, the company plans to change the 
capital structure in the future. And although the WACC can be adjusted yearly according to 
the change in the debt-equity ratio, it is a complex process (Groves & Knott 2013). Therefore, 
in these cases the APV model should be adopted. The APV values the firm as if it was all 
funded by equity and then adding the financial effects of debt to this value (tax shields such as 
the value created by deductible interests): !"# = !"  !"  !"  !"#$%&'  !"#  !""  !"#$%&  !"#$#%&' + !"#$#%&  !"#$%  !"  !"#  !ℎ!"#$%   
To obtain the EV as if the company was all equity financed, the FCF without tax shields are 
discounted at rate of unlevered cost of equity12.  The value of tax shields should be discounted 
at the rate that appropriately reflects the risk of these tax shields (for interest related tax 
shields it should be the cost of debt) (Damodaran, 2011; Koller et al., 2010; Lopes, 2012).  
So, the difference between APV and Enterprise models is in how they deal with tax shields. 
Whereas in the first these benefits are explicitly measured, in the latter the value created by 
tax shields is incorporated through the WACC.  
                                                
10 The term 1 −   !!  represents additional value generated by the deductible interests (a tax shield). So in EP and classic DCF models, the 
value obtained from the deductible interests is incorporated through the WACC. 
11 To know how to compute a synthetic rate for private companies please consult: (Damodaran, 2011) 
12 The rate of unlevered cost of equity is the cost of equity as if the company had no debt.  
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Finally, it must be pointed out that in certain periods a company may not be able to use the tax 
shields (or part of them) because the profits from that year aren´t greater than the value of tax 
shields. In these cases the jurisdiction where the company operates must be analyzed in order 
to know how to calculate and treat the tax shields effects. (Koller et al., 2010) 
Equity cash flow model 
The equity cash flow model values equity directly by accessing the future CFs to equity and 
discounting them at cost of equity. The main difference to the previous presented methods 
relies in the calculation of the CFs. To calculate them, the effects of debt financing are built 
into the CFs rather than into the cost of capital (as it was made on the enterprise models 
valuation) (Damodaran, 2011). This means adding to the FCF calculated in previous 
enterprise methods, increases and decreases in debt and the related effect of paid interests. 
Also the non-operating assets non-consider in the FCF from enterprise models, should now be 
consider to calculate the CF to equity. 
(Koller et al., 2010) consider that is difficult to implement correctly and can easily lead to 
errors. For example, when a company increases its debt the cost of equity should be adjusted 
to reflect the additional risk imposed on equity holders and by using this method this is not 
done (Koller et al., 2010). However they use it for valuating financial institutions, since in 
those cases it is difficult to separate value of operations and debt. Damodaran (2011) has a 
similar opinion on this model and states that estimating CFs with this model can became 
problematic and “as a rule, firm valuation is a more flexible approach than equity valuation”. 
He argues that the equity CF model should only be used if business has a stable leverage. 
4.2.4. Terminal value 
As mentioned before, in the long term the CFs becomes difficult to forecast. And therefore 
usually the value of operations is usually divided in explicit forecast period and after explicit 
forecasted period. To value the second term a TV is used. There are a lot of approaches for it 
and the appropriate one depends on the characteristics of the business under valuation. 
(Damodaran, 2011) gives three options to estimate terminal value: multiple approaches - 
using a multiple of the EBIT or EBITDA - a stable growth model or a liquidation model.  
When using a DCF model to value the business it doesn´t make sense to use the multiple 
approach since it would bring elements of relative valuation into the DCF valuation. So in this 
case, the choice would be between the stable growth or the liquidation model (Damodaran, 
2011)). However, he states that the TV in a significant number of discounted CFs valuations 
is estimated using a multiple.  
The liquidation model consists in valuing the firm, as it would shut down in the last year of 
the explicit forecast period. So it is suggested to use when the “assets are separable and   
marketable” (Damodaran, 2011)). 
The stable-growth model consists in assuming that the revenues will grow at a constant rate 
and that the WACC will be constant. And in a scenario like this the analyst can use a 
perpetuity-based formula to calculate the TV, which is calculated as follows: 
!!! = !!!!!!"## − !"#$%ℎ  !"#$ 
This perpetuity-based formula can also be used to value the present value of entire business, 
by applying it to the current year’s earnings. Although it is a rough estimation (a small 
Competitive Intelligence and Business valuation in the Healthcare IT industry 
45 
variance in growth or WACC yields a great variance in the value) it is a simple approach to 
the value of the business and therefore it is often used in discussions about a deal start to 
determine if discussions can or should continue (Moeller & Brady, 2014).  
4.3. Multiples valuation 
Multiples valuation, also known as relative valuation, consists in valuating an asset by 
looking at the price it has been paid during transactions (acquisitions) or is being paid in the 
market (market capitalization of public companies) to comparable assets. Using a multiple 
valuation has the advantage of being simple to use - requires less information - and easier to 
communicate (Damodaran, 2011). Besides, it reflects the relative market valuations, being 
therefore free from the evaluator manipulations and influences. However it is often difficult to 
find adequate comparable firms and the fact that they are market-based can also be a 
disadvantage, since markets can be under or overvalued (Moeller & Brady, 2014).  
To standardize the value, common variables are used. These common variables are usually 
operational-based variable such as EBIT, EBITDA and Revenue (Damodaran, 2011; Koller et 
al., 2010; Moeller & Brady, 2014; River Cities Capital Funds, 2011).  Other variables also 
used are book values or sector-specific variables such as web site visits per day for internet-
based companies (Damodaran, 2011).  Although there are a lot of possible multiples to arrive 
at a market-based valuation for the company, the most common used are the EV-to-EBITA 
and EV-to-EBITDA ratio, since they are easier accessed. (Koller et al., 2010) states that these 
two multiples should be used every time it is possible because by using them the analyst 
“mitigates problems with capital structure and one-time gains or losses”. However to be 
possible to use them, the company must have positive operating incomes - 
Comparable businesses or firms should be similar in some key operating metrics such as 
EBITDA or EBIT margins (relative to revenues), revenue growth and ROIC (Koller et al., 
2010; River Cities Capital Funds, 2011; Scott, 2010). Besides being similar in its financial 
and operational profile, the company comparable should have similar size and operate in the 
same or similar space, i.e. same industry and same target market (Scott, 2010).  
Multiples can be extracted from public companies (public multiples or trading multiples) or 
from recent transactions (mergers or acquisitions). Usually multiples from transactions are 
higher than multiples based on the market (public companies), because in the first case it is 
included a control premium, i.e. a premium that the acquirer is willing to pay over market 
price for the ability to have control over the company  and extract synergies (Venema, 2007). 
When valuing a private business based on public multiples, even if the public company is 
very similar to the business under analysis, the analyst should take into account that public 
companies normally have higher revenue multiples than private companies, because they have 
better access to investment capital, which lowers their financial risk (Venema, 2007). 
Moreover, they usually have better management team, larger revenues bases and user bases as 
well as markets to their shares, which is valued by the stock owners (Venema, 2007). So in 
order to compensate this higher value of the revenue multiple for public companies, analysts 
should apply a discount when calculating the value for a private-held company based on 
public-held companies multiples (Venema, 2007). When looking at public companies, a peer 
group of comparable companies should be used. It is also useful to do this approach at 
different levels such as sector, market and industry level (Koller et al., 2010). To compute the 
multiples from the different levels the median or harmonic median of the multiple should be 
used so that the estimation is less influenced by the outliers (Koller et al., 2010). Furthermore, 
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multiples should be based on forecast earnings rather than on historical, since the first 
represent the value better than the latter. When forecasts aren´t available the valuation should 
be focused on most recent multiples available (Koller et al., 2010). 
After having calculated and gathered different multiples, the analyst has different ways too 
choose the value estimation based on them. By averaging all the different multiples obtained, 
what has the disadvantage of mixing the multiples with poor quality with high quality. By 
computing a weighted average of all multiples estimations, where the weight of the multiple 
is usually attributed to its precision (what might be difficult). Or following the approach 
suggested by (Moeller & Brady, 2014) that is to pick the multiples, that makes more sense to 
use in that valuation being conducted. 
4.4. Selection of valuation methods and specification of their implementation  
Koller et al. (2010) uses the enterprise DCFs methods to valuate businesses, since they 
consider them as being the most accurate and flexible methods. Because of the benefits from 
each one of them, they use both EP and classic DCF method.  However for companies whose 
operations are related to financing, the CF to equity method is used. They also state as being 
good practice to calculate the value of operations with the DCF models4 for two or even three 
scenarios (bad, normal and optimistic scenario) and estimate a probability of the occurrence 
of these scenarios. The final value of operations should be calculated with a weighted average 
of the value of the three scenarios. Besides the valuation through DCF methods, Koller et al. 
(2010) use multiples in order to test the estimations made in the DCF valuation and to identify 
possible mismatches with the comparable companies, what will also yield productive 
discussions about the valuation. 
Supporting the way that Koller et al. (2010) typically perform a valuation, a study conducted 
by Imam et al. (2008) revealed that approximately 60% of the analysts inquired expressed 
strong preference for CF based valuation methods, particularly when on buy-side. During the 
study was also found that most of the analysts often complemented the CF-based analysis 
with multiples-based analysis. Regarding the models they adopted, the study revealed that the 
most widely used valuation method was classic DCF (few used EP model) and the most used 
multiple was the EV-to-Earnings ratio. 
Damodaran (2011) states that 50% of all acquisition valuations are based upon multiples and 
that objective in “many DCF valuations is to back into a number that has been obtained by 
using multiple-based valuation”. Similarly to Koller et al. (2010), he also argues that since a 
DCF valuation is function of its inputs, what-if analysis should be conducted to address the 
potential future outcomes. He suggests 3 different approaches to deal with potential future 
outcomes. The first is to build a probabilistic approach based on the 3 plausible different 
scenarios. The second is estimating the most pessimist scenario and the most optimistic 
scenario. And the third is to build a scenario sensible to particular inputs and analyze how the 
value is affected by changing these particular inputs. 
Another possible approach to execute a valuation suggested by Moeller & Brady (2014) 
consists in using different methods - DCF methods with different scenarios, book value and a 
set of multiples valuation - and calculate the final valuation by applying a relative weighted 
average to the value estimated with the different methods. In this approach, the aspects of the 
business under analysis should determine the weighted average. For example, in a business 
where the balance sheet is more liquid, more weight should be given to the book valuation 
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method. On the other hand, if there a great number of recent transactions then more weight 
should be given to the market multiples.  
4.4.1. Valuating software and SaaS companies 
Before getting to the valuation methods used for software companies it is important to note 
that these type of companies have special aspects that other industries don´t pursue and 
therefore should be treated differently. For example, a typical financial and operational 
analysis addresses metrics on a year basis, whereas in software companies this can be 
misleading since they have software development and sales cycles that together can last much 
more than one year. For these reasons a 18-24 month statement about operating and profit 
metrics represents better the cycle of the business than the typical 12-month bases (Chalfin, 
2006). (Corum Group)  a specialized company in software, IT and internet related technology 
companies, also mention that these companies should have different valuation approaches 
than other kind of business, because of their different characteristics such as being almost in 
bankruptcy or losing money and still can worth a great amount of money. They assert that the 
valuation methods usually used for software companies are usually based on comparable 
transactions, because it is the simplest way to valuate. Furthermore, they consider the EV-to-
sales ratio to be the most popular multiple, because it can be applied to companies with losses 
or minimal income. 
Specifically for valuating software companies, (Venema, 2007) states that although the 
valuation of a software company can involve the three approaches – market, asset and income 
based – the focus is usually given to the market-based approach.  
As he argues, asset-based valuations aren’t appropriate for software companies because the 
most assets of the software companies are intangible assets, which are not subject to objective 
valuation. Besides, this type of valuation fails to address some important value creators (such 
as software that is being under development) and value damagers (such as delays in launch of 
new software that have lost the market momentum).  He also argues that DCF approaches 
aren´t appropriate, since the historical performance of software companies often fail to predict 
the future performance of the company. 
So, he concludes that a market-based valuation should be used for software companies, giving 
specially attention to the individual sector in which the company operates. That´s because 
within software and IT services subsectors the multiples vary by much. Consequently, the 
comparable company or group should not only be similar in their profitability and size but 
also must operate in the same sub-sector. 
Addressing particularly the valuation of SaaS companies, (River Cities Capital Funds, 2011) 
states that while all type of companies are ultimately valued on the present value of their 
DCF, industry analysts tend to rely more on comparable multiples of revenue and EBITDA 
for valuing SaaS businesses. To define comparable companies, analyst use companies with 
similar revenue growth, capital efficiency and market size.  
4.5. Business valuation project at the company 
During the project at the company, a business valuation from a particular business was 
conducted. It is impossible to reveal specific details about the business aspects, purpose of the 
valuation or results, because of the confidentiality to which the project is submitted. However 
the approach followed for the valuation will be described without violating any type of 
confidentiality issues. 
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The valuation method adopted in the project was the classic DCF method. The results were 
then compared to a set of multiples from different types of groups and companies in order to 
put the valuation in the proper context and to understand if it deviates significantly from the 
market and transactions valuations.  
This approach was adopted because of several reasons. First, the classic DCF approach is the 
preferred method of the company. Second, the valuation has also relied heavily on the DCF 
valuation, because the internal factors that drive the future CFs from the business under 
analysis were easily identified and quantified and therefore a good estimation of the future 
CFs could be done. The variance of future CFs was more dependent on external factors than 
on internal factor, which are stable and predictable. This issue has been addressed by 
conducting an analysis of the external environment and by computing different scenarios on 
the DCF valuation. 
For the external business analysis, a full profile of the healthcare IT market for the business 
under analysis was made. For that to be achieved, macro-economic analysis, competitors’ 
analysis, market sizing, estimation of the growth of the market as well as analysis of the 
different stakeholders of the industry were conducted. This business analysis wasn´t fully 
under the thesis author responsibility, although he has contributed to its development, 
especially on the market sizing, competitive landscape analyses and healthcare industry 
analysis. Also for the internal factors analysis, the author has contributed by analyzing and 
extracting information from documents about the business under analysis. 
For the DCF valuation, together with the manager expert in the business and market under 
analysis, three possible scenarios – pessimist, normal and optimistic - were forecasted in order 
to have valuation estimates for each of them. Before this phase, the financial statements items 
and their forecasted values were analyzed and discussed together with the management 
supervision from Siemens in order to identify possible errors and adjustments that should be 
done.  
The WACC at which the CFs are discounted, must be provided by the financial department of 
the company since the company uses standards WACC - in function of region, industry, 
purpose of the valuation among other aspect from the business under analysis. So, there was 
no need to calculate the cost of equity and cost of debt in order to obtain the WACC. 
The TV was assumed to be the liquidation value in the worst and normal scenario. This 
approach has been chosen because for these scenarios it was considered that the liquidation 
value was a good indicator of the value in the end of the forecast period, and also because it 
fitted into the assumptions of the scenarios and the purpose of the valuation. The TV for the 
optimistic scenario was calculated based on the perpetuity formula, assuming a stable growth 
of the business – based on market analysis executed - and a constant WACC. 
In order to compare the valuations estimated with the DCF model, a set of multiples were 
calculated and gathered. As suggested in the literature, and because it was difficult to find 
similar business, different peer groups were considered: companies with the same target 
market or at least operating partially in the same market; transactions; main competitors that 
are public traded; public companies operating in the same subsectors (HIT, SaaS and HIT 
services); and multiples from public companies at an industry level (Software, IT and 
computer companies). Whenever possible, the EBITDA margin and Revenue growth of the 
company (or the mean of the group) were gathered, in order to know if the operating and 
financial profile from the comparable group is similar to the business under analysis (see 
Figure 21). 
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Figure 21 - Multiples peer groups 
The comparison was made having in mind that the majority of the public companies have all 
of their operations in the US, where the HIT companies have higher valuation than companies 
in the markets where the business under analysis operates. Furthermore, as suggested in the 
literature, it was also taken into account that public companies tend to have a higher value 
than non-public companies. 
When comparing with recent transactions, the fact that the value from transactions are higher 
than public companies and consequently than private companies was also taken into account. 
Although the literature suggest to give more focus to the market comparison valuation when 
valuating software companies, in this case the multiples haven´t played a significant role on 
the valuation, because it was impossible to find adequate comparable companies or involved 
EV/EBITDA EV/REVENUE Ebitda margin Rev growth LTM
Bad Scenarion YYx ZZx
Normal Scenario YYx ZZx
Optimistic Scenario YYx ZZx
Similar company 1 7.20x 1.00x 13.2% -3.9%
Similar company 2 8.00x 0.60x 7.4% 18.8%
Similar company 3 16.50x 0.64x 8.9% 3.2%
Similar company 4 6.00x 0.80x 10.0% -5.0%
HIT (all transactions) 12.00x 2.07x - -
HIT (<$30m)) 1.67x 8.20x - -
HIT ($30m-$100m)) 2.42x 12.60x - -
HIT (>$100m)) 2.35x 13.20x - -
IT and Services       
(last 20 years) - 2.25x - -
Vertical SAAS        (last 
24 months) - 2.50x - -
Horizontal SaaS         
(last 24 months) - 3.60x - -
Software 15.00x 2.50x - -
Allscripts 16.20x 2.60x 16.0% 16.0%
CGM 10.80x 2.30x 22.0% 8.0%
Cerner 16.60x 5.70x 35.0% 35.0%
HIS services 17.00x 3.50x 21.0% 11.0%
HIT systems 16.00x 3.50x 15.0% 8.0%
Healthcare software 19.80x 2.60x 0.0% 0.0%
Healthcare Services 9.36x - 0.0% 0.0%
HIT 17.65x - 0.0% 0.0%
IT Consulting 9.50x 2.20x 0.0% 0.0%
Information 13.80x 3.50x 0.0% 0.0%
Software companies 17.00x 5.00x 0.0% 0.0%
Computer Services 9.51x - 0.0% 0.0%
Computer Software 12.67x - 0.0% 0.0%
Operating figures
Business under 
analysis XX% XX%
Public companies 
(Industry level) 
Comparable 
companies Sector /industry
Multiples
Same (or similar) 
target market
Transactions
Competitors public 
traded
Public companies  
(Subsector level) 
Competitive Intelligence and Business valuation in the Healthcare IT industry 
50 
in recent transactions. This happened because of the specificities of the market where the 
business analyzed operates, as well as the particular aspects of its operations. 
In the end, rather than one single valuation, three valuations for three different scenarios were 
considered. These valuations for the different scenarios will serve as a framework to support 
the managers when attributing a price to the business and negotiating that price (to pay or 
receive from the negotiation13). 
4.6. Conclusion of business valuation 
It is important to note that the business valuation project was not the main project of this 
master thesis because of two reasons. First less time was devoted to it, and second because the 
project is confidential and therefore wasn´t possible to disclose any details of the project. This 
would make it to include it in the master thesis and to confront the tasks done during the 
project with the literature review. 
Also because this wasn´t the main project, the literature reviews wasn´t as deep as it should be 
if the master thesis was fully devoted to the topic of valuation. For example, a relevant topic 
in valuation is the estimation of the cost of equity and cost of debt. This topic should be more 
deeply analyzed and studied. But because in the project the WACC was provided and because 
the author couldn´t address all the important topics, these two weren´t addressed in great 
detail. 
The application of the DCF valuation method wasn´t a very complex process since most of 
the information was provided and the future performance was easily forecasted. Furthermore, 
the aspects of the business were relative simple leading to an easy estimation of the present 
value of the operations.  
Therefore, it is believed that this project was more fruitful in terms of the experience gained. 
Being involved in the process of valuation enabled the author to understand the dynamics of 
the people involved in it, and to understand the differences between practice and theory, i.e. 
understand that a valuation goes well beyond the mathematical calculations to reach a final 
value. 
Damodaran (2011) says that valuation is more an art than a science. During the project this 
has been confirmed, since it was noticed that the values obtained from the valuation 
techniques are only useful as a starting point, and managers don´t rely completely on them. 
All the rest that is involved in a valuation and negotiation process - external environment, 
purpose, and strategy goals, among others - also weight significantly in the final valuation of 
the business, and are ultimately reflected on the price paid or received from it. 
	  
 
                                                
13 It was not possible to disclose in which side - buyer or seller - was this business valuation situated. 
Competitive Intelligence and Business valuation in the Healthcare IT industry 
51 
5. Conclusion 
The CIF developed for the BD department satisfies the goals identified before the project: to 
create a framework that would support an ongoing process of gathering and storing specific 
data about competitors, and to provide managers with important and updated information 
about the competitors in a comprehensive way. However, the department’s needs may change 
over time and the person in charge for the CIF should pay attention to this evolution and adapt 
its structure so that it addresses new needs of the department and managers.  
It is believed that the HS division should learn from this pilot project and adapt it with 
broader scope. The HS CI activities in the HS division are in a very early stage and therefore 
in an ideal stage for implementing a platform that would address competitors’ issues. In this 
case, as it was suggested, the platform should definitely be developed by an IT team and 
installed in the intranet with a robust structure. This solution would be ideal, because it would 
address what is believed to be the most powerful source of information for CI activities: 
internal information that flows between employees and that is hidden in the departments and 
inside employees’ heads. Furthermore, it would also have the advantage of having all 
employees contributing to the CI intelligence of HS division, what is also believed to be 
crucial in CI activities. Only one or two persons can´t do a good job in gathering all the 
information needed, to get good insights from competitors. In case such a platform is not 
possible to develop, the CIF developed in this project for the int BD department should be 
adapted and integrated in the shared storage location from the whole HS division, so that all 
employees can use it and contribute to it. 
At last, regarding the second project from this master thesis, related to business valuation, in 
normal circumstances it should have been addressed in a more extensive way, by conducting 
deeper analysis of the internal and external factors of the business. This was not done, because 
first this was a secondary project of the master thesis and therefore the time devoted to it 
didn´t enable to do so. Second, because other members of the team were already in charge of 
the other parts of the valuation process and therefore it wouldn´t make sense for the author to 
be also working on them. And third, because the access to all the documents related to the 
business was restricted - and not accessible to the author - due to the confidentiality profile 
that this project has. However, despite the fact that the project didn´t cover the whole 
valuation process and tasks related to the valuation, it is believed that the author has 
contributed for a better valuation of the business. 
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ANNEX A: Siemens Healthcare organizational chart 
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ANEXO B: Business Development Department  
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ANEXX D: CI comparison between Brazil and North America 
companies  
 
Figure 22 - Comparison between CI activities among Brazil and North America (Blenkhorn & 
Fleisher, 2007) 
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ANEXX D: Dashboard from CI Framework 
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ANEXX E: Calculation of NOPLAT, FCF and equity value through 
classic DCF method 
Calculation of NOPLAT: 
 
Calculation of FCF to use in classic DCF model: 
 
 
Calculation of equity through classic DCF model: 
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ANEXX F: Calculation Economic profit and equity value through 
Economic Profit method 
 
Calculation of Economic profit: 
 
Calculation of equity through EP model: 
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ANEXX G: Option A to adapt the CIF to the HS division 
 
 
 
Figure 23 - Option A to adapt the CIF to the HS division 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Competitive Intelligence and Business valuation in the Healthcare IT industry 
65 
ANEXX H: Frequencies of the phases adopted 
 
 
Figure 24 - Frequencies of phases adopted 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
